JUNE 25-28, 2020 WHITE NIGHTS

St. Petersburg InternationalOncology Forum

JUNE 25-28, 2020

WHITE NIGHTS

Рrogram* (preliminary)

*Please note that the Programme might be subject to change

June 25

25.06.2020

Start(Moscow

time)

End(Moscow

time)

Duration Report title Full name of a Speaker/Chairman

Institution City

Stream № 1 (studio — Petrov NMRC)10:00 11:00 1:00 Opening video speeches to the participants of the Forum11:00 13:20 Cancer care in Russian Federation

Chairs: Andrey Kaprin FSBI NMRRC of the Ministry of Health of Russia MoscowIvan Stilidi FSBI «N.N. Blokhin NMRC of oncology» of the

Ministry of Healthcare of the Russian FederationMoscow

Andrey Karitskiy FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:00 11:05 0:05 Opening session Aleksey Belyaev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:05 11:20 0:15 Strategy for cancer care: international and local approaches

Andrey Kaprin FSBI NMRRC of the Ministry of Health of Russia Moscow

11:20 11:35 0:15 Challenges in cancer care Ivan Stilidi FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

11:35 11:50 0:15 Current situation with cancer care in Russia Valeriy Starinskiy P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

11:50 12:05 0:15 Cancer screening and early detection: background, initial results and struggles

Rustem Khasanov Kazan State Medical Academy - branch of FSBEI FPE RMACPE MOH Russia

Kazan

12:05 12:20 0:15 Cancer care in terms of health insurance system of Saint-Petersburg

Vadim Stozharov Territorial compulsory medical insurance fund of St. Petesburg

St. Petersburg

12:20 12:35 0:15 Current state of cancer care in Siberian Federal District: problems and perspectives

Evgeny Choynzonov Tomsk National Research Medical Center of the Russian Academy of Science

Tomsk

12:35 12:50 0:15 Current state of cancer care in Saint-Petersburg Dmitry Gladyshev St. Petersburg SBHI City hospital №40 St. Petersburg12:50 13:05 0:15 Current problems in access to cancer care for

patients in high-volume Centers: management options.

to be specified FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:05 13:20 0:15 Discussion13:20 15:00 1:40 Stream break15:00 18:00 RUSSCO (Russian Society of Clinical Oncology)

Moderator Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Nikolai Zhukov Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

15:00 15:10 0:10 Opening session Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:10 15:45 0:35 The impact of COVID-19 on cancer care: new reality

Nikolai Zhukov Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

15:45 15:50 0:05 Questions and answers15:50 16:25 0:35 Integration of molecular diagnostics into clinical

oncology: old and new tests, legislative and economic issues

Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:25 16:30 0:05 Questions and answers16:30 17:00 0:30 Clinical and economic issues of pathology report Nikita Savelov Moscow city oncology hospital №62 Moscow17:00 17:05 0:05 Questions and answers17:05 17:40 0:35 Increasing sensitivity of genetic testing in patients

with hereditary colorectal cancerAleksey Tsukanov FSBI «A.N. Ryzhikh State scientific

coloproctology center» of the Ministry of Health of Russia

Moscow

17:40 17:45 0:05 Questions and answers17:45 18:00 0:15 Discussion

Stream №2 (studio — Pribaltiyskaya)9:00 10:40 Innovations in oncogynecology: surgery

Chairs Irakli Todua Multidisciplinary Medical Center «Innova» Tbilisi, GeorgiaArtem Stepanyan Medical Center «Nairi» Yerevan, Armenia

9:00 10:40 1:40 Life surgery: laparoscopy with signal lymph nodes mapping in endometrial cancer treatment.

Igor Berlev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:40 12:00 Innovations in gynecologic oncology: video course10:40 11:00 0:20 Comparative characteristics of the four molecular

biological types of endometrial cancer detected according to modern classification: endocrinology, receptor phenotype, macrophage-lymphocyte infiltration, clinical implications

Lev Bershteyn FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:00 11:20 0:20 Video presentation “Upper abdominal procedures in ovarian cancer surgery”

Artem Stepanyan Medical Center «Nairi» Yerevan, Armenia

11:20 11:40 0:20 Video presentation “Devisceration in the surgical treatment of gynecological cancer”

Irakli Todua Multidisciplinary Medical Center «Innova» Tbilisi, Georgia

11:40 12:00 0:20 Discussion12:00 16:45 Melanoma and skin tumors: controversaries in clinical practice

Moderator Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Georgiy Gafton FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Lev Demidov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Daniil Stroyakovskiy Moscow city oncology hospital №62 Moscow12:00 12:15 0:15 Current situation with melanoma treatment: ups

and downsSvetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the

Ministry of Healthcare of the Russian FederationSt. Petersburg

12:15 12:30 0:15 Updated guidelines in terms of COVID-19 pandemic

Galina Kharkevich FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:30 12:40 0:10 Signal lymph nodes biopsy, what challenges in routine practice?

Grigoriy Zinoviev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:40 12:50 0:10 Igor Samoylenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

25.06.2020

12:50 13:00 0:10

Signal lymph nodes biopsy, what challenges in routine practice?

Sergey Gamayunov SBHI of the Nizhny Novgorod Region «Nizhny Novgorod Regional Oncologic Center»

Nizhny Novgorod

13:00 13:15 0:15 Is there a place for surgery in the era of new therapeutic agents?

Vitaly Egorenkov SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

13:15 13:25 0:10 Discussion13:25 13:30 0:05 Break13:30 13:30 Issues in management of patients with brain metastases13:30 13:40 0:10 Oncologist perspective Aleksey Novik FSBI «N.N. Petrov NMRC of oncology» of the


13:40 13:50 0:10 Radiologist perspective Andrey Golanov FSAI N.N. Burdenko Institute of Neurosurgery of the ministry of Health of Russia

Moscow

13:50 14:00 0:10 Neurosurgeon perspective Evgeny Prozorenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:00 14:10 0:10 Discussion14:10 14:15 0:05 Break14:15 15:30 Melanoma and concominant conditions14:15 14:30 0:15 Melanoma and pregnancy Anastasia Parokonnaya FSBI «N.N. Blokhin NMRC of oncology» of the

Ministry of Healthcare of the Russian Federation; FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov»

Moscow

14:30 14:40 0:10 Clinical cases Ani Oganesyan FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:40 14:50 0:10 Melanoma and concomitant diseases Irina Koroleva University «Reaviz» Samara14:50 15:00 0:10 Melanoma and concomitant diseases: hepatitis,

HIVEkaterina Anokhina St Petersburg University; N.I. Pirogov Clinic for

High Medical TechnologySt. Petersburg

15:00 15:10 0:10 Melanoma and concomitant diseases: renal failure, dialysis

Natalia Petenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

15:10 15:20 0:10 Melanoma and concomitant diseases: clinical case(supported by Roche)

Natalia Zhukova St.-Petersburg City Oncology Clinic St. Petersburg

15:20 15:30 0:10 Discussion15:30 15:35 0:05 Break15:35 16:45 Controversaries in squamous cell carcinoma of the skin management15:35 15:45 0:10 Squamous cell carcinoma of the skin: current

state of the problem(supported by Sanofi)


St. Petersburg

15:45 15:55 0:10 Mohs — surgery in the squamous cell carcinoma of the skin treatment

Igor Samoylenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

15:55 16:05 0:10 Head and neck squamos cell carcinoma Olga Ponomareva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:05 16:20 0:15 Merkel carcinoma: what’s new in treatment? Kristina Orlova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

16:20 16:40 0:20 Discussion16:40 16:45 0:05 Chairs’ closing speech16:45 17:00 0:15 Break17:00 18:30 1:30 BIOCAD symposium

Do we Need another PD-1 Inhibitor? A Forum of Public OpinionModerator Nikolai Zhukov Dmitry Rogachev National Medical Research

Center Of Pediatric Hematology, Oncology and Immunology

Moscow

17:00 17:05 0:05 Opening address and video17:05 17:10 0:05 Present Your Evidence Elena Artamonova FSBI «N.N. Blokhin NMRC of oncology» of the


17:10 17:25 0:15 The Efficacy of Prolgolimab: What do we Know? Daniil Stroyakovskiy Moscow city oncology hospital №62 Moscow17:25 17:40 0:15 The Safety of Prolgolimab: the Expected and

UnexpectedSvetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the


17:40 17:50 0:10 The Experience of one Center: What will Happen if Patients are Correctly Selected?

Fedor Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

17:50 18:10 0:20 The Evolution of Immunotherapy for Melanoma and the Place of the New PD-1 Inhibitor

Alexander Eggermont the Princess Maxima Center and DKFZ German Cancer Research Center HeidelbergGermany

18:10 18:20 0:10 Differences of Prolgolimab from Other Immune Checkpoint Inhibitors


St. Petersburg

18:20 18:30 0:10 ConclusionStream №3 (studio — Pribaltiyskaya)

10:00 11:00 1:00 Opening video speeches to the participants of the Forum 11:00 18:40 Congress II CEEBCSC (Central East European Breast Cancer Surgery Consortium)11:00 12:30 Session 1. Contemporary approaches to surgical management of breast cancer (simultaneous translation support)

Moderator Petr Krivorotko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Aleksey Belyaev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Zoltan Matrai National institute of Oncology HungaryThorsten Kuhn Klinikum Esslingen GermanyVladimir Semiglazov FSBI «N.N. Petrov NMRC of oncology» of the


11:00 11:15 0:15 Welcome/Greetings Aleksey Belyaev, Vladimir Semiglazov, Криворотько Пётр Владимирович, Zoltan Matrai

11:15 11:30 0:15 What's new from the latest BC conferences (SABCS, ASCO, EBCC)

Aleksander Bessonov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:30 11:45 0:15 Regional thinking, regional acting in the field of breast cancer, Project CEEBCSC

Zoltan Matrai National institute of Oncology Hungary

11:45 12:00 0:15 Improving surgical breast cancer care by international cooperation

Thorsten Kuehn Klinikum Esslingen Germany

12:00 12:15 0:15 The state of oncoplastic and reconstructive surgery in breast cancer patients in St. Petersburg

Garik Dashyan St.-Petersburg City Oncology Clinic St. Petersburg

25.06.2020

12:15 12:30 0:15 Discussion12:30 12:35 0:05 Break12:35 14:05 Session 2. Reducing risk in state-of-the-art breast surgery (simultaneous translation support)

Moderator Aleksander Bessonov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Ashutosh Kothari Guy's & st thomas' nhs foundation United Kingdom12:35 12:50 0:15 Resection margins in breast-conserving surgery

as primary care and after neoadjuvant therapy (should there be a different approach?)

Bahadir M. Gulluoglu Marmara University School of Medicin Istanbul, Turkey

12:50 13:05 0:15 The role of the contralateral prophylactic mastectomy

Alexandru Blidaru University of Medicine and Pharmacy “Carol Davila”, Institute of Oncology Bucharest “Prof. Dr. Al. Trestioreanu”, President of the Romanian Society of Breast Surgery and Oncology

Bucharest

13:05 13:20 0:15 Surgery of the axilla after neoadjuvant therapy Janez Zgajnar The institute of Oncology, Ljubljana Slovenia13:20 13:35 0:15 Does neoadjuvant chemotherapy affect surgery

extent?Aleksander Petrovskiy FSBI «N.N. Blokhin NMRC of oncology» of the


13:35 13:50 0:15 Breast cancer surgery in BRCA-mutation carriers (is more - less or less is more?)

Arthur Avetisyan National Center of Oncology after V. A. Fanarjyan Armenia

13:50 14:05 0:15 Discussion14:05 14:10 0:05 Break14:10 15:40 Session 3. Radiotherapy in reconstructive and oncoplastic resections: does timing matter? (simultaneous translation support)


St. Petersburg

Chairs Alexandru Blidaru University of Medicine and Pharmacy “Carol Davila”, Institute of Oncology Bucharest “Prof. Dr. Al. Trestioreanu”, President of the Romanian Society of Breast Surgery and Oncology

Bucharest

Vladimir Sobolevskiy FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Sergey Novikov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Arthur Avetisyan National Center of Oncology after V. A. Fanarjyan Armenia14:10 14:25 0:15 Raiotherapy, when its effictive? Sergey Novikov FSBI «N.N. Petrov NMRC of oncology» of the


14:25 14:40 0:15 Subpectoral reconstruction and radiotherapy Sergey Malygin FSBEI Pirogov Russian National Research Medical University

Moscow

14:40 14:55 0:15 Prepectoral reconstruction and radiotherapy Azizzhon Zikiryakhodzhaev P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

14:55 15:10 0:15 Radiotherapy and immediate breast reconstruction.

Christoph Andree Klinik fur Plastische und Asthetische Chirurgie Sana Kliniken Dusseldorf GmbH

Germany

15:10 15:25 0:15 Radiotherapy and oncoplastic surgery David Murawa University Hospital, Clinic of General Surgery and Surgical Oncology

Poland

15:25 15:40 0:15 Discussion15:40 15:45 0:05 Break15:45 17:00 Session 4. Surgery of complicated cases (simultaneous translation support)

Moderator Aleksander Bessonov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Artur Ismagilov Kazan State Medical Academy - branch of FSBEI FPE RMACPE MOH Russia

Kazan

15:45 16:00 0:15 Reaching optimal symmetry - shadow-boxing or a path to OLYMPUS?

Vladimir Karasev MCMM Euromed Omsk

16:00 16:15 0:15 Personal approaches in my practice to prevent complications

Elbrus Baychorov Stavropol regional oncological center Stavropol

16:15 16:30 0:15 NAC preservation in ptosis breast reconstruction Igor Chizh Pavlov First St.Petersburg State Medical University

St. Petersburg

16:30 16:45 0:15 Breast cancer surgery after previous aesthetic operations

Elena Bit-Sava SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

16:45 17:00 0:15 Discussion17:00 17:05 0:05 Break17:05 18:05 Session 5. To Infinity and Beyond (simultaneous translation support)


St. Petersburg

Chairs Azizzhon Zikiryakhodzhaev P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

Zoltan Matrai National institute of Oncology HungaryChristoph Andree Klinik fur Plastische und Asthetische Chirurgie

Sana Kliniken Dusseldorf GmbHGermany

17:05 17:20 0:15 Oncoplastic resections in patients with small / medium breast size: advantages and disadvantages

Yuliana Shatova National Medical Research Centre for Oncology Rostov-on-Don

17:20 17:35 0:15 New methods of covering a synthetic implant / expander in breast cancer reconstructive surgery

Olga Khodorovich FSBI Russian Scientific Center of Roentgenoradiology (RSCRR) of the Ministry of Healthcare of the Russian Federation

Moscow

17:35 17:50 0:15 The future is FAT Ashutosh Kothari Guy's and St Thomas' NHS Foundation Trust Великобритания17:50 18:05 0:15 Discussion18:05 18:10 0:05 Break18:10 18:40 Session 6. To be continued. Clinical case discussion. NORTH vs everyone

Moderators Elbrus Baychorov Stavropol regional oncological center StavropolPetr Krivorotko FSBI «N.N. Petrov NMRC of oncology» of the


Members of the NORTH team Sergey Ereshchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Aleksander Emelyanov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Roman Pesotskiy FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

25.06.2020

Remote team members Natalia Shevchenko National Medical Research Centre for Oncology Rostov-on-DonMarianna Starkova P.A. Hertsen Moscow Oncology Research Center

- branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

Ilnur Kamaletdinov SAHI «Republican oncologacal clinacal dispansary of the Ministry of Healthcare of the Republic of Tatarstan»

Kazan

Stream №4 (studio — Pribaltiyskaya)10:00 11:00 1:00 Opening video speeches to the participants of the Forum 11:00 15:30 Epidemiology, registration and cancer screening11:00 13:00 Session 1. Cancer epidemiology, registration and screening (joint session with IARC) — Part 1 (simultaneous translation support)

Moderator Anton Barchuk FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation; University of Tampere

St. Petersburg

11:00 11:30 0:30 Global burden of cancer Freddie Bray IARC Lyon, France11:30 12:00 0:30 Cancer registration in former USSR countries Ariana Znaor IARC Lyon, France12:00 12:30 0:30 Cancer registry networks in Asia Malcolm Moore Khon Kaen University Khon Kaen,

Thailand12:30 13:00 0:30 Discussion13:00 13:30 0:30 Break13:30 15:30 Session 2. Cancer epidemiology, registration and screening (joint session with IARC) — Part 2 (simultaneous translation support)


St. Petersburg

13:30 14:00 0:30 Cancer burden in Ukraine Anton Ryzhov National Cancer Institute Kiev, Ukraine14:00 14:30 0:30 Cancer screening in 5 continents Partha Basu IARC Lyon, France14:30 15:00 0:30 Nordscreen Veli-Matti Partanen Finnish Cancer Registry Helsinki, Finland15:00 15:30 0:30 Discussion15:30 16:00 0:30 Stream break16:00 19:20 European School of Oncology: «How to optimally approach rare cancers?» (simultaneous translation support)

Moderator Vladimir Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

Сo-moderator Aleksander Fedenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia; FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Paolo Giovanni Сasali IRCCS National Cancer Institute & University of Milano

Milan, Italy

16:00 16:15 0:15 Welcome address Vladimir Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

16:15 16:45 0:30 Which cancers are rare? And why? And what to do, then?

Annalisa Trama IRCCS National Cancer Institute & University of Milano

Milan, Italy

16:45 17:15 0:30 Soft tissue sarcomas: which presentations and treatment pathways should be clinically optimized and how?

Paolo Giovanni Сasali IRCCS National Cancer Institute & University of Milano

Milan, Italy

17:15 17:45 0:30 Rare gastrointestinal cancers: which presentations and treatment pathways should be clinically optimized and how?

Robert Glynne-Jones Mount Vernon Hospital, Watford and Barnet General Hospitals

London, United Kingdom

17:45 18:15 0:30 Head & Neck cancers: which presentations and treatment pathways should be clinically optimized and how?

Lisa Licitra IRCCS National Cancer Institute & University of Milano

Milan, Italy

18:15 18:45 0:30 What are we doing in Russia? Aleksander Fedenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia; FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

18:45 19:00 0:15 Perspectives for cooperation and conclusions Paolo Giovanni Сasali IRCCS National Cancer Institute & University of Milano

Milan, Italy

19:00 19:20 0:20 DiscussionStream №5 (studio — Pribaltiyskaya)

10:00 11:00 1:00 Opening video speeches to the participants of the Forum 11:00 13:45 Current aspects of malignant pleural mesothelioma diagnostics and treatment (simultaneous translation support)

Moderator Nikolai Krotov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:00 11:20 0:20 Multidisciplinary treatment of malignant pleural mesothelioma - the Vienna experience

Stefan B. Watzka Karl Landsteiner Institute of Thoracic Oncology, Vienna North Hospital

Vienna, Austria

11:20 11:40 0:20 Pleural mesothelioma: pathogenesis and morphological diversity

Anna Artemyeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:40 12:00 0:20 A multimodal approach in pleural mesothelioma treatment (experience of N. N. Petrov Oncology NMRC)

Evgeny Levchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:00 12:20 0:20 Discussion12:20 12:25 0:05 Break12:25 12:45 0:20 Pleural mesothelioma radiation treatment: another

chance or disappointing expectations?Natalia Dengina State healthcare clinical oncology center Ulyanovsk

12:45 13:05 0:20 A critical look at pleural mesothelioma treatment Tatiana Barbolina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:05 13:25 0:20 Preoperative and intraoperative staging of the mediastinum

Michael Müller Clinic Vienna North Vienna, Austria

13:25 13:45 0:20 Discussion13:45 14:30 0:45 Stream break14:30 18:30 Pharmacoeconomics in oncology14:30 16:25 Session 1 (simultaneous translation support)

Moderator Andrey Pavlysh North-western State Medical University named after I.I.Mechnikov; FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

25.06.2020

14:30 14:50 0:20 Early benefit assessment of drugs Liberman Ana Institute for Quality and Efficiency in Health Care Cologne, Germany14:50 15:10 0:20 Extraordinary strengths but also weaknesses of

the German regulatory system to ensure quality, efficiency and responsible pricing of innovative pharmaceuticals

Rupprecht Christoph J. AOK Rheinland/Hamburg – Die Gesundheitskasse

Dusseldorf, Germany

15:10 15:25 0:15 Real clinical practice data. From a glossary to oncology practice

Aleksey Kolbin Pavlov First St.Petersburg State Medical University

St. Petersburg

15:25 15:40 0:15 The use of real clinical practice survival data for pharmacoeconomic assessment of the drugs administration feasibility

Irina Vilyum Pavlov First St.Petersburg State Medical University

St. Petersburg

15:40 15:55 0:15 Real clinical practice data in cancer care Aleksey Kurylev Pavlov First St.Petersburg State Medical University; FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:55 16:10 0:15 Pragmatic clinical trials Olga Shevchenko Pavlov First St.Petersburg State Medical University

St. Petersburg

16:10 16:25 0:15 Discussion16:25 16:40 0:15 Break16:40 18:30 Session 2

Moderator Aleksey Kolbin Pavlov First St.Petersburg State Medical University

St. Petersburg

16:40 16:55 0:15 Financial burden of modern pharmacotherapy in oncology: can the costs be reduced?

Sergey Zyryanov RUDN University Moscow

16:55 17:10 0:15 Clinical and economic approaches to the development of new clinical statistical groups for nutritional support of cancer patients after chemotherapy

Olga Zelenova Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Moscow

17:10 17:25 0:15 Hospital assessment of healthcare technologies in Russia: principles of organization and performance

Andrey Pavlysh North-western State Medical University named after I.I.Mechnikov; FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

17:25 17:40 0:15 Survival rate modeling in pharmacoeconomic studies

Svyatoslav Plavinskiy North-western State Medical University named after I.I.Mechnikov

St. Petersburg

17:40 17:55 0:15 Pharmacoeconomic aspects of cancer patients vaccination to prevent pneumococcal infection

Alla Rudakova FSBEI Saint Petersburg State Chemical Pharmaceutical Academy of the Ministry of Healthcare of Russia

St. Petersburg

17:55 18:10 0:15 Developing scales for healthcare methods and pricing assesment in oncology in Russia: benefits and struggles

Vitaly Omelyanovskiy Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Moscow

18:10 18:30 0:20 Discussion. Closing address. Adoption of a resolution following the section results

Stream №6 (studio — Pribaltiyskaya)10:00 11:00 1:00 Opening video speeches to the participants of the Forum 11:00 19:35 Evolutionary oncology and evolutionary virology11:00 15:00 Session 1. Evolutionary virology (simultaneous translation support)

Chairs Andrey Kozlov Vavilov Institute of General Genetics Russian Academy of Sciences; Peter the Great St. Petersburg Polytechnic University

St. Petersburg

Dmitry Lioznov Smorodintsev Research Institute of Influenza St. PetersburgAndrey Komissarov Smorodintsev Research Institute of Influenza St. Petersburg

11:00 11:25 0:25 Clinical and epidemiological characteristics of COVID-19 in Russia

Dmitry Lioznov Smorodintsev Research Institute of Influenza St. Petersburg

11:25 11:50 0:25 Coronavirus: an old and new pathogen Andrey Vasin Institute of Biomedical Systems and Technologies of Peter the Great St. Petersburg Polytechnic University; Smorodintsev Research Institute of Influenza

St. Petersburg

11:50 12:15 0:25 Genetic characteristics of SARS-CoV-2 viruses detected in Russia

Andrey Komissarov Smorodintsev Research Institute of Influenza St. Petersburg

12:15 12:30 0:15 CORONAVIRUS FUTUROLOGY: Visible and invisible consequences for cancer patients diagnosed also with COVID-19 and for those who still have to get infected

Ancha Baranova School of Systems Biology, George Mason University Functional Genomics, Human Genetics, Personalized Medicine, Biomarkers, Bioinformatics

Manassa, Virginia, USA

12:30 12:55 0:25 Mortality and life expectancy in connection with the COVID-19 epidemic

Aleksey Golubev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:55 13:20 0:25 Parallels in Response to the COVID-19 and HIV / AIDS Epidemics

Saulius Caplinskas Centre for Communicable Diseases and AIDS Vilnius, Lithuania

13:20 13:30 0:10 Analysis of mutation D614G S protein in various isolates of SARS-CoV

Andrey Makashov FSUE State Research Institute of Ultrapure Biologicals of the Federal medical-biological agency; Vavilov Institute of General Genetics Russian Academy of Sciences

St. Petersburg

13:30 13:40 0:10 Identification of Covid-19 in different patient groups

Vladimir Eremin SI «Republican Scientific and Practical Center for Transfusiology and Medical Biotechnology»

Minsk, Belarus

13:40 13:55 0:15 Discussion13:55 14:00 0:05 Break14:00 14:15 0:15 Expression of the reverse transcriptase domain of

telomerase reverse transcriptase induces lytic cellular response in DNA-immunized mice and limits tumorigenic and metastatic potential of murine adenocarcinoma 4T1 cells

Maria G Isaguliants N.F.Gamaleya Research Institute of Epidemiology and Microbiology; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian ; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Riga Stradiņs University, Riga, Latvia

Moscow, Stockholm, Sweden, Riga, Latvia

14:15 14:30 0:15 Exosomal and integrated human papilloma virus type 16 in squamous cervical carcinomas of women with HIV-1 and M tuberculosis infections of varying cancer stage, grade and degree of inflammation-associated immune suppression

Maksim Vonsky D.I.Mendeleyev Institute for Metrology; FSBI Almazov National Medical research Center of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:30 14:45 0:15 Role of the microbiome in potentiating development of human papillomavirus-associated high grade squamous intraepithelial lesions

Joel Palefsky University of California San Francisco - UCSF San Francisco, USA

14:45 15:00 0:15 Discussion15:00 16:00 1:00 Break16:00 19:35 Session 2. Evolutionary oncology (simultaneous translation support)

25.06.2020

Chairs Andrey Kozlov Vavilov Institute of General Genetics Russian Academy of Sciences; Peter the Great St. Petersburg Polytechnic University

St. Petersburg

Constantinos Voskarides Medical School, University of Cyprus Nicosia, Cyprus16:00 16:30 0:30 The current status of the theory of carcino-evo-

devoAndrey Kozlov Vavilov Institute of General Genetics Russian

Academy of Sciences; Peter the Great St. Petersburg Polytechnic University

St. Petersburg

16:30 17:00 0:30 Cancer genes are essential for evolutionary adaptation. Is cancer a side-effect of evolution?

Constantinos Voskarides Medical School, University of Cyprus Nicosia, Cyprus

17:00 17:30 0:30 Placental Immune Editing Switches Hypothesis (PIES) : does escape from immune vigilance in carcinogenesis imply the ectopic epigenetic and genomic activation (or suppression) of immune regulatory circuits derived from the evolution of feto maternal tolerance in mammals with invasive placentation?

Miguel Hernandez-Bronchud Génesis Care Corachan Barcelona, Spain

17:30 18:00 0:30 Transgenerational transient epialleles: a possible molecular genetic basis for the relationship between processes of ontogenesis, oncogenesis and phylogenesis?

Nikolai Yankovsky Vavilov Institute of General Genetics Russian Academy of Sciences

Moscow

18:00 18:30 0:30 Regulatory variants in vertebrate genomes: role in phylogenesis and ontogenesis, in the norm and the pathology

Vsevolod Makeev Vavilov Institute of General Genetics Russian Academy of Sciences

Moscow

18:30 18:40 0:10 The study of the expression of human endogenous retroviruses as related to their evolutionary novelty

Andrey Makashov FSUE State Research Institute of Ultrapure Biologicals of the Federal medical-biological agency; Vavilov Institute of General Genetics Russian Academy of Sciences

St. Petersburg

18:40 19:10 0:30 Cancer as cellular cheating: The evolutionary roots of cancer and the future of cancer control

Athena Aktipis Arizona State University Phoenix metropolitan area, USA

19:10 19:35 0:25 DiscussionStream № 7 (studio — Pribaltiyskaya)

10:00 14:00 Surgical coloproctology10:00 14:00 4:00 Illustrative demonstration of surgical interventions

(supported by Johnson&Johnson)Aleksey Karachun FSBI «N.N. Petrov NMRC of oncology» of the


Aleksey Petrov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Stream № 8 (studio — Pribaltiyskaya)8:00 17:45 Actual issues of cancer patients rehabilitation8:00 10:00 Session 1. COVID19 and cancer patients rehabilitation: temporary recommendations

Moderators Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Boris Kasparov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Elena Melnikova Pavlov First St.Petersburg State Medical University

St. Petersburg

8:00 8:30 0:30 Changes in the medical rehabilitation system of the Russian Federation

Galina Ivanova FSBEI Pirogov Russian National Research Medical University

Moscow

8:30 8:45 0:15 New things in COVID19 patient rehabilitation Elena Melnikova Pavlov First St.Petersburg State Medical University

St. Petersburg

8:45 9:00 0:15 Issues with cancer patients rehabilitation after COVID19-associated pneumonia

Konstantin Lyadov Lyadov Clinics Moscow

9:00 9:15 0:15 Physiotherapeutic rehabilitation methods for cancer patients after COVID

Tatiana Konchugova FSBI «NMRC of Rehabilitation and Balneology» of the Ministry of Healthcare of the Russian Federation

Moscow

9:15 9:30 0:15 Telemonitoring and telerehabilitation as an auxiliary tool for helping cancer patients during a pandemic

Irina Kargalskaya Russian Patients Association Moscow

9:30 9:45 0:15 COVID-19 pandemic stress management guidelines for cancer patients and healthcare professionals

Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:45 10:00 0:15 Discussion10:00 11:00 1:00 Opening video speeches to the participants of the Forum 11:00 12:25 Session 2. Nutritional support is an important component of cancer patients treatment and rehabilitation (simultaneous translation support)

Chairs Marina Kukosh SBHI «City clinical hospital №40» of the Moscow City Department of Health

Moscow

Olga Obukhova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow


St. Petersburg


St. Petersburg

11:00 11:30 0:30 How to support oncological patients during COVID-19: special focus on nutrition & continuum of care with an update from ESMO recommendations

Alessandro Laviano Sapienza Università di Roma Rome, Italy

11:30 11:45 0:15 Medical and economic aspects of nutritional therapy of in cancer patients

Elena Gameeva P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

11:45 12:00 0:15 Medical and economic efficacy of enteral nutrition in in cancer patients. St. Petersburg’s experience (supported by Nutricia Specialized Nutrition)

Georgiy Manikhas St. Petersburg

12:00 12:15 0:15 Role of nutritional support in rehabilitation of patients with gastrointestinal cancer

Olga Obukhova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:15 12:25 0:10 Discussion12:25 12:30 0:05 Break12:30 14:10 Session 3. Clinical studies in cancer patients rehabilitation


St. Petersburg


St. Petersburg

25.06.2020

Chair Elena Filonenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

12:30 12:45 0:15 Work by P.A. Hertsen Moscow Oncology Research Center in the framework of the clinical trial protocol “Comprehensive rehabilitation of breast cancer patients”

Elena Filonenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

12:45 13:00 0:15 Results of comprehensive rehabilitation of orthopedic cancer patients

Aleksandra Stepanova Medical and Diagnostic Center «Recovery» Moscow

13:00 13:15 0:15 Biopsychosocial approach in the rehabilitation of operable breast cancer patients

Valeria Klyuge FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:15 13:30 0:15 Algorithms for a comprehensive assessment of nutritional status and trophologic insufficiency correction in patients with locally advanced gastric cancer receiving neoadjuvant chemotherapy

Nadezhda Brish FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:30 13:45 0:15 Criteria for efficacy assessment of cancer patients rehabilitation

Rezeda Bodrova SAHI «Hospital for war veterans» Kazan

13:45 14:00 0:15 Assessment of emotional burnout syndrome in oncologists following the example of the Republic of Tatarstan

Sufiya Safina SAHI «Republican oncologacal clinacal dispansary of the Ministry of Healthcare of the Republic of Tatarstan»

Kazan

14:00 14:10 0:10 Discussion14:10 14:15 0:05 Break14:15 16:05 Session 4. Oncopsychology

Moderators Margarita Vagaytseva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


St. Petersburg

Chairs Valentina Chulkova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Tatiana Karavaeva V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology

St. Petersburg

14:15 14:30 0:15 Main directions of psychosocial rehabilitation of cancer patients after amputation of lower limbs

Ekaterina Usmanova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:30 14:45 0:15 Recovery of cancer patient 's family function during treatment

Svetlana Proshchenko St.-Petersburg City Oncology Clinic St. Petersburg

14:45 15:00 0:15 Assessment of the needs for psychological assistance when reporting a primary diagnosis

Svetlana Lobanova BHI Oryol region «Oryol Oncologic Center» Oryol

15:00 15:15 0:15 Mythologization of psychosomatic relations in cancer, as a protective strategy of a psychologist

Nadezhda Vasilyeva V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology

St. Petersburg

15:15 15:30 0:15 Subjective assessment of the quality of life of breast cancer patients with brain metastases

Mayya Zakharova Dr. Berezin Medical Institute St. Petersburg

15:30 15:45 0:15 Aspects of psychological adaptation of cancer patients

Ilmira Khusainova Kazakh Institute of Oncology and Radiology Kazakhstan, Almaty

15:45 16:05 0:20 Discussion16:05 16:10 0:05 Break16:10 17:45 Session 5. Session of young cancer psychology scientists


St. Petersburg


St. Petersburg

Chairs Kristina Kondratieva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Nadezhda Vasilyeva V.M. Bekhterev National Medical Research Center of Psychiatry and Neurology

St. Petersburg

16:10 16:25 0:15 Antivital experiences of cancer patients Kristina Kondratieva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:25 16:40 0:15 Emotional state of parents of children during radiotherapy

Valentina Kozlova FSBEI HE St. Petersburg Pediatric Medical University of the Ministry of Healthcare of Russian Federation

St. Petersburg

16:40 16:55 0:15 Rehabilitation of pre-school patients suffering from hemoblastosis

Olesya Morozova Pavlov First St.Petersburg State Medical University

St. Petersburg

16:55 17:10 0:15 Cognitive impairment in cancer patients during BMT

Tatiana Kerpataya Pavlov First St.Petersburg State Medical University

St. Petersburg

17:10 17:25 0:15 Features of relationships in breast cancer patients Aleksandra Gorbunova Pavlov First St.Petersburg State Medical University

St. Petersburg


10:00 11:00 1:00 Opening video speeches to the participants of the Forum 12:00 13:00 1:00 Novartis symposium (simultaneous translation support)

Moderator Igor Samoylenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:00 12:30 0:30 5 years data of RFS in the patients with the resectable BRAF positive melanoma. Combi A/D Trial

Axel Hauschild Department of Dermatology University of Kiel institution

Kiel, Germany

12:30 12:40 0:10 Discussion Igor Samoylenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:00 13:30 0:30 Break13:30 14:30 1:00 Novartis symposium

Science yesterday, real clinical practice today (simultaneous translation support)Moderator Lyudmila Zhukova A.S. Loginov Moscow Clinical Scientific Center Moscow

13:30 13:40 0:10 Transformation of aBC treatment goals: aiming at overall survival increase

Anton Snegovoy FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:40 14:00 0:20 CDK4/6 in routine clinical practiсe in Germany Nadia Harbeck Comprehensive Cancer Center of the Ludwig-Maximilians-University

Munich, Germany

14:00 14:10 0:10 CDK4/6 in the first line: changing the fates of our patients Irina Kolyadina

FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:10 14:30 0:20 PIK3CA mutation. Do we have a new BC subtype?

Joseph Gligorov Sorbonne University and Tenon Hospital, Paris (APHP)

Paris, France

14:30 14:40 0:10 SOLAR-1 trail. One more step towards personalized therapy of breast cancer

Elena Artamonova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:40 14:50 0:10 Alpelisib. First real-world evidence. Efficacy and control of adverse events

Lyudmila Zhukova A.S. Loginov Moscow Clinical Scientific Center Moscow

25.06.2020

14:30 15:00 0:30 Break15:00 16:00 1:00 MSD symposium

Immunotherapy: novel treatment approaches for advanced endometrial cancerModerator Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the


15:00 15:10 0:10 Endometrial cancer drug treatment Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:10 15:35 0:25 Novel treatment approaches for endometrial cancer with high microsatellite instability (MSI-H) / deficiency in mismatch repar (dMMR) system

Svetlana Khokhlova FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov»

Moscow

15:35 16:00 0:25 Pembrolizumab + lenvatinib combination in the treatment of endometrial cancer without MSI-h / dMMR Aleksandra Tjulyandina


Moscow

16:00 16:30 0:30 Break16:30 17:30 1:00 Lilly Pharma symposium

The new generation of CDK4 and 6 inhibitors. Do we use all opportunities in the treatment of patients with HR+ HER2- advanced MBC?Moderator

16:30 16:50 0:20 Inhibitors of cyclin-dependent kinases: Moving Forward

Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg

16:50 17:05 0:15 The use of abemaciclib in late lines treatment for HR-positive HER2-negative metastatic breast cancer. Presentation of a clinical case

Inna Ganshina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

17:05 17:25 0:20 New treatment options for patients with HR + HER2- metastatic breast cancer with adverse prognostic factors


St. Petersburg

17:30 18:00 0:30 Break18:00 19:00 1:00 Servier symposium

Moderator Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Co-Moderators Rashida Orlova St.-Petersburg City Oncology Clinic St. PetersburgElena Artamonova FSBI «N.N. Blokhin NMRC of oncology» of the


18:00 18:05 0:05 Introduction Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg18:05 18:20 0:15 Modern approach to mCRC treatment according

to international guidelinesAleksey Tryakin FSBI «N.N. Blokhin NMRC of oncology» of the


18:20 18:35 0:15 Searching for optimal decisions for patients benefit: late-line mCRC therapy


Moscow

18:35 18:50 0:15 Novel oral mCRC treatment: Clinical experience Fedor Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

18:50 18:55 0:05 Questions and answers18:55 19:00 0:05 Conclusion Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg

June 26

26.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

Stream № 1 (studio — Petrov NMRC)10:00 14:00 Mediastinal tumors: surgery10:00 14:00 4:00 Live surgery: mediastinal tumor resection via

subxiphoid approachEvgeny Levchenko FSBI «N.N. Petrov NMRC of oncology» of

the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:00 14:00 4:00 Live surgery: mediastinal tumor resection via sternotomy approach

Porkhanov Vladimir Krasnodar

Stream №2 (studio — Pribaltiyskaya)8:50 13:50 VI Conference named after M.L. Gershanovich. "What's new in cancer systemic therapy"


St. Petersburg

Chairs Aleksey Belyaev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Irina Poddubnaya FSBEI of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation

Moscow

8:50 9:00 0:10 Opening session Aleksey Belyaev, Irina Poddubnaya

9:00 9:30 0:30 Personalized haemato-oncology: a new reality? Irina Poddubnaya FSBEI of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation

Moscow

9:30 10:00 0:30 New generation of drug sensitivity tests Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:00 10:30 0:30 Tumor evolution and drug treatment prospects Vladimir Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

10:30 11:00 0:30 Antitumor response activation — a new treatment strategy in breast cancer patients

Sergey Tyulyandin FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

11:00 11:30 0:30 Drug therapy as an element of multidisciplinary approach in patients with head and neck squamos cell carcinoma

Larisa Bolotina P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

11:30 12:00 0:30 Gastrointestinal cancer: what do we know, what do we have?


12:00 12:30 0:30 Non-small cell lung cancer: small molecules — great significance

Lyubov Vladimirova National Medical Research Centre for Oncology

Rostov-on-Don

12:30 13:00 0:30 Drug treatment of melanoma Years later... Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:00 13:30 0:30 Key changes in systemic cancer therapy Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:30 13:40 0:10 Discussion13:40 13:50 0:10 Closing session13:50 14:00 0:10 Stream break14:00 17:15 Delivering best cancer care: local experiences in acheving the targets14:00 15:35 Session 1.

Moderator Irina Laricheva Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Moscow

Chair Aleksey Belyaev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:00 14:25 0:25 How cancer incidence and mortality statistics for cancers of common sites shapes the regional epidemiological pattern

Irina Laricheva Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Moscow

14:25 14:55 0:30 Economic aspects of a clinic performance as factors for targets achievement

Olga Obukhova Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation

Moscow

14:55 15:20 0:25 Access to anti-cancer drugs as the key to better outcomes in cancer patients

Aleksey Rumyantsev FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

15:20 15:35 0:15 Discussion15:35 15:40 0:05 Break15:40 15:40 Session 2.15:40 16:00 0:20 Progress in early cancer diagnosis: experience of

the Sakhalin regionVladimir Yushchuk / Ivan Ambrazhuk

Ministry of Health of the Sakhalin Region Yuzhno-Sakhalinsk

16:00 16:20 0:20 Improving cancer screening by centralization and standartization of the study protocols: Tambov region experience

Vladimir Milovanov SBHI «Tambov Regional Oncologic Center»

Tambov

16:20 16:40 0:20 Organization of follow-up visits for patients with precancerous lesions and cancer

Elena Grebenkina SBHI of the Nizhny Novgorod Region «Nizhny Novgorod Regional Oncologic Center»

Nizhny Novgorod

16:40 17:00 0:20 Discussion17:00 17:15 0:15 Closing session

Stream №3 (studio — Pribaltiyskaya)9:00 12:45 Breast cancer: from bench to bedside9:00 10:30 Session 1. Mentor session. Who will do this tomorrow?

Moderator Garik Dashyan St.-Petersburg City Oncology Clinic St. Petersburg

26.06.2020

Chairs Azizzhon Zikiryakhodzhaev P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

Irina Kolyadina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Yuliana Shatova National Medical Research Centre for Oncology

Rostov-on-Don

9:00 9:15 0:15 Opening session Garik Dashyan, Azizzhon Zikiryakhodzhaev, Irina Kolyadina, Yuliana Shatova

9:15 9:30 0:15 Treating axillary web syndrome with type A botulinum toxin

Marianna Starkova P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

9:30 9:45 0:15 Prognostic and predictive factors of stage II–III triple negative cancer

Olga Gordeeva FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

9:45 10:00 0:15 Is it possible to preserve nipple-areolar complex for centrally localized tumors?

Natalia Shevchenko National Medical Research Centre for Oncology

Rostov-on-Don

10:00 10:15 0:15 Adjuvant treatment of residual breast cancer after neoadjuvant systemic therapy

Sergey Ereshchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:15 10:30 0:15 Discussion10:30 10:35 0:05 Break10:35 11:50 Session 2. Breast cancer. Educational session. Modern standards and approaches


St. Petersburg

10:35 11:00 0:25 Breast cancer surgical treatment Eldar Topuzov St.-Petersburg City Oncology Clinic St. Petersburg11:00 11:25 0:25 Breast cancer radiotherapy Oksana Trofimova FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

11:25 11:50 0:25 Breast cancer systemic therapy Marina Stenina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

11:50 12:05 0:15 Discussion12:05 12:05 Session 3. Breast cancer. Educational session. New areas in breast cancer treatment.12:05 12:35 0:30 What's new in breast cancer treatment in 2020:

review of St. Gallen, ESMO and ASCO materialsVladimir Semiglazov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

12:35 12:45 0:10 Discussion12:45 14:00 1:15 Stream break14:00 18:00 VI Conference named after M. L. Gershanovich "Personalized therapy: from bench to bedside": personalized therapy for breast cancer patients14:00 15:50 An oncologist’s glossary: what? where? to whom?


St. Petersburg


St. Petersburg

14:00 14:20 0:20 TILs in an oncologist’s glossary: what? where? to whom?


St. Petersburg

14:20 14:40 0:20 PDL in an oncologist’s glossary: what? where? to whom?(supported by Roche)

Larisa Zavalishina FSBEI of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation

Moscow

14:40 15:00 0:20 BRCA in an oncologist’s glossary: what? where? to whom?


St. Petersburg

15:00 15:20 0:20 CD4/6 in an oncologist’s glossary: what? where? to whom?(supported by Lilly)


St. Petersburg

15:20 15:40 0:20 PI3CA in an oncologist’s glossary: what? where? to whom?(supported by Novartis)

Lyudmila Zhukova A.S. Loginov Moscow Clinical Scientific Center

Moscow

15:40 15:50 0:10 Discussion15:50 16:00 0:10 Break16:00 18:00 Breast cancer treatment philosophy (simultaneous translation support)


St. Petersburg

Petr Krivorotko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:00 16:25 0:25 Surgical treatment evolution in the era of breast cancer systemic treatment

Vahit Ozmen Department of Surgery Istanbul University of Istanbul Medical Faculty Capa

Istanbul, Turkey

16:25 16:50 0:25 Breast cancer: what is good and what is bad Nikolai Zhukov Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

16:50 17:10 0:20 Luminal breast cancer: what's new in understanding protocol design, efficacy and toxicity assessment

Vladislav Semiglazov Pavlov First St.Petersburg State Medical University

St. Petersburg

17:10 17:30 0:20 Triple negative breast cancer: we've only just begun

Mona Frolova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

17:30 17:50 0:20 HER2+ breast cancer: moving forward from simple to complex

Petr Krivorotko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

17:50 18:00 0:10 Conclusive sessionStream №4 (studio — Pribaltiyskaya)

9:00 15:15 Multimodal approach to imaging-based diagnosis of neck soft tissue tumors: from the simple to the complex

26.06.2020

9:00 12:05 Session 1. Focal changes of the thyroid gland and parathyroid glands. World trends and domestic perspectives. Pathology of salivary glands and regional lymph nodes (simultaneous translation support)Moderator Lev Shevkunov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Chairs Dmitry Vasilyev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Ekaterina Busko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Larisa Krasilnikova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Ekaterina Kostromina FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:00 9:20 0:20 Role of an endocrinologist in diagnosis of thyroid cancer

Dmitry Vasilyev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:20 9:40 0:20 Cytological diagnosis of thyroid cancer: state of the art

Larisa Krasilnikova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:40 10:00 0:20 TI-RADS classification. Stratification of thyroid nodules. Russian version.

Elena Fisenko FSBSI «Petrovsky National Research Centre of Surgery»

Moscow

10:00 10:20 0:20 Multiparameter ultrasound examination of focal thyroid changes. Current imaging techniques


St. Petersburg

10:20 10:40 0:20 Discussion10:40 10:45 0:05 Break10:45 11:05 0:20 Parathyroid ultrasound when, why and how to do

it?Gerasimos Sykiotis University Hospital Lausanne, Switzerland

11:05 11:25 0:20 Multiparameter investigation of ultrasound in the primary diagnosis of large salivary glands and lymph nodes.

Gerasimos Sykiotis University Hospital Lausanne, Switzerland

11:25 11:45 0:20 Radiology in the differential diagnosis of salivary glands tumor and non-tumor changes.

Evgenya Bubnova Pavlov First St.Petersburg State Medical University

St. Petersburg

11:45 12:05 0:20 Discussion12:05 12:10 0:05 Break12:10 15:15 Session 2. Imaging-based diagnosis of orofacial tumors: oral cavity, nasopharynx, larynx. New horizons

Moderator Lev Shevkunov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Anna Artemyeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


St. Petersburg

Olga Ponomareva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


St. Petersburg

Zamira Radzhabova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:10 12:30 0:20 Morphological aspects of oral cavity, nasopharynx, larynx tumors


St. Petersburg

12:30 12:50 0:20 Differential diagnosis of non-malignant and malignant changes in the pharyngeal ring tonsils


St. Petersburg

12:50 13:10 0:20 Differential diagnosis of skull base tumors and tumor like lesions

Elena Stepanova Moscow regional Research and Clinical Institute

Moscow

13:10 13:30 0:20 Tongue cancer — initial MR diagnosis and monitoring tumor response


St. Petersburg

13:30 13:50 0:20 Discussion13:50 13:55 0:05 Break13:55 14:15 0:20 Differential radiology diagnosis of orofacial lesions Yuri Vasilyev SBHI «Clinical Science Centre for

Diagnosis and Telemedicine Technology of the Moscow City Department of Health»

Moscow

14:15 14:35 0:20 Imaging-based diagnosis of head and neck cancer: preoperative planning and postoperative follow-up in microsurgical interventions

Yulia Vasilyeva A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Moscow

14:35 14:55 0:20 The Neck Imaging Reporting and Data System — capabilities of radiological diagnostic methods for monitoring the treatment results in patients with head and neck cancer


St. Petersburg

14:55 15:15 0:20 Discussion15:15 16:00 0:45 Break16:00 17:00 1:00 Johnson & Johnson symposium16:00 17:00 1:00 The destruction of a legend. No nephrectomy Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

17:00 17:30 0:30 Break17:30 18:30 1:00 Eisai symposium

Moderator Larisa Bolotina P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

26.06.2020

17:30 17:35 0:05 Symposium opening Larisa Bolotina P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

17:35 17:50 0:15 Clinical case: lenvatinib in combination with everolimus in the treatment of metastatic kidney cancer

Aleksey Kalpinskiy P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

17:50 17:55 0:05 Clinical Case CommentsElena Shavarova

Department of Propaedeutics of Internal Medicine, Peoples' Friendship University

Moscow

17:55 18:00 0:05 Clinical Case Comments

Evgenia Shatokhina

Medical Research and Education Center of Moscow State University named after MV Lomonosov

Moscow

18:00 18:20 0:20 Clinical case: lenvatinib in the treatment of radioiodine refractory differentiated thyroid cancer

Ekaterina Borodavina

A. Tsyb Medical Radiological Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Obninsk

18:20 18:25 0:05 Clinical Case CommentsElena Shavarova

Department of Propaedeutics of Internal Medicine, Peoples' Friendship University

Moscow

18:25 18:30 0:05 Summarizing Larisa Bolotina P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

18:30 19:00 0:30 BreakStream №5 (studio — Pribaltiyskaya)

9:00 15:00 Mythbusters9:00 11:40 Legend about locally advanced and metastatic prostate cancer drug treatment (simultaneous translation support)

Moderators Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Sergey Petrov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Bertrand Tombal University Hospital St. Luc at the University of Leuven (Belgium)

Leuven, Belgium

Vsevolod Matveev FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Boris Alekseev P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow


St. Petersburg

9:00 9:20 0:20 A myth was born: 100 years’ evolution of the theory of prostate cancer hormone-dependent carcinogenesis

Vsevolod Matveev FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

9:20 9:40 0:20 Myth busted: current studies of prostate cancer hormone resistance (supported by Astrazeneca)


Moscow

9:40 10:00 0:20 Myth busted: safety of hormonal manipulations in men

Sergey Petrov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:00 10:20 0:20 Myth busted: is the strategy of chemotherapy in metastatic prostate cancer dead?(supported by Sanofi)

Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:20 10:40 0:20 A legend born: how far are modern ideas on the prostate cancer molecular carcinogenesis from hormone-dependent theory


St. Petersburg

10:40 11:00 0:20 A legend that wasn't born: can drug therapy expand indications for prostate cancer surgical treatment in case of poor and very poor prognosis?

Bertrand Tombal University Hospital St. Luc at the University of Leuven (Belgium)

Leuven, Belgium

11:00 11:10 0:10 Changes of morphological and immunohistochemical characteristics of prostate adenocarcinoma during neoadjuvant systemic therapy

Maria Berkut FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:10 11:20 0:10 Results of neoadjuvant drug therapy prior to radical prostatectomy in patients with oligometastatic prostate cancer

Kirill Nyushko A. Tsyb Medical Radiological Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

11:20 11:40 0:20 Discussion11:40 12:40 1:00 Break12:40 15:00 Legend about locally advanced and metastatic kidney cancer drug treatment

Moderators Maria Volkova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Rashida Orlova St.-Petersburg City Oncology Clinic St. PetersburgSvetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Denis Nosov FSBI «Clinical Hospital» MoscowSergey Petrov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg


St. Petersburg

12:40 13:00 0:20 Legend decline and rebirth: renal cancer immunotherapy yesterday and today

Anna Semenova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:00 13:20 0:20 Is the legend dead? Is targeted monotherapy for kidney cancer possible today?


St. Petersburg

13:20 13:40 0:20 Living legend: multiple targeted therapies for kidney cancer (supported by Eisai, Ltd.)

Maria Volkova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:40 14:00 0:20 Merge of the legends: combined targeted and Immunotherapy for kidney cancer


26.06.2020

14:00 14:20 0:20 A legend that wasn't born: does interstitial ablation for kidney cancer trigger immune response? Clinical results of localized kidney cancer ablation

Aleksey Kalpinskiy P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

14:20 14:40 0:20 A legend that wasn't born: does interstitial ablation for kidney cancer trigger immune response? Results of assessment of a systemic and local immune response to kidney cancer interstitial ablation.


St. Petersburg

14:40 15:00 0:20 Discussion15:00 15:30 0:30 Break15:30 16:30 1:00 IPSEN symposium

Moderator Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:30 15:35 0:05 Introduction15:35 15:45 0:10 Overview of existing options among TCI. Why do

we need new TCI?Vsevolod Matveev FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

15:45 16:00 0:15 Cabozantinib and the first generation of TKI: data in clinical trials and place in recommendations.

Larisa Zavalishina FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:00 16:20 0:20 Cabozantinib and current representatives of TCI: data in clinical trials and place in recommendations.


Moscow

16:20 16:30 0:10 Discussion: Closing of the symposiumStream №6 (studio — Pribaltiyskaya)

9:00 13:00 Joint meeting of ESGO, RSGO: innovations in gynecological oncology9:00 9:15 Opening session (simultaneous translation support)

Moderator Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Jalid Sehouli Charite - Universitätsmedizin Berlin Berlin, GermanyIgor Berlev FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Nadeem Abu Rustum Memorial Sloan Kettering Cancer Center, USA

New York, USA

Lev Ashrafyan FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov»

Moscow

Elena Ulrikh FSBI Almazov National Medical research Center of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:00 9:05 0:05 Introduction of ESGO Jalid Sehouli Charite - Universitätsmedizin Berlin Berlin, Germany9:05 9:10 0:05 Introduction of RSGO Elena Ulrikh FSBI Almazov National Medical research

Center of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:10 9:15 0:05 Submission of memorandum Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:15 9:20 0:05 Break9:20 10:50 Session 1. Ovarian cancer (simultaneous translation support)

Moderator Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:20 9:35 0:15 Imaging tools for the ovarian cancer diagnosis Valeria Saevets SBHI «Chelyabinsk Regional Center for Oncology and Nuclear Medicine»

Chelyabinsk

9:35 9:50 0:15 Identification of the peritoneal carcinomatosis index in patients with advanced ovarian cancer

Igor Berlev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:50 10:05 0:15 Neoadjuvant therapy form primary ovarian cancer Aleksey Shevchuk FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

10:05 10:20 0:15 Value of surgery in relapsed ovarian cancer Jalid Sehouli Charite - Universitätsmedizin Berlin Berlin, Germany10:20 10:35 0:15 Drug therapy in recurrent ovarian cancer Elena Ulrikh FSBI Almazov National Medical research


St. Petersburg

10:35 10:50 0:15 Discussion10:50 10:55 0:05 Break10:55 11:55 Session 2. Endometrial cancer (simultaneous translation support)

Moderator Elena Ulrikh FSBI Almazov National Medical research Center of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:55 11:10 0:15 SLN In endometrial cancer: a modern staging approach

Nadeem Abu Rustum Memorial Sloan Kettering Cancer Center, USA

New York, USA

11:10 11:25 0:15 Drug therapy for early endometrial cancer Olga Novikova P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

11:25 11:40 0:15 Drug therapy in advanced and recurrent endometrial cancer

Adilia Urmancheeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:40 11:55 0:15 Discussion11:55 12:00 0:05 Break12:00 13:00 Session 3. Cervical cancer (simultaneous translation support)

Moderator Igor Berlev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:00 12:15 0:15 Detection of signal lymph nodes in the cervical cancer treatment

Christhardt Köhler Asklepios Klinik Altona Hamburg, Germany

26.06.2020

12:15 12:30 0:15 Endovideosurgery in cervical cancer treatment Igor Berlev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:30 12:45 0:15 Drug therapy for cervical cancer Elena Ulrikh FSBI Almazov National Medical research Center of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:45 13:00 0:15 Discussion13:00 13:30 0:30 Stream break13:30 15:30 Vaccination in oncology: do we improve forecasts or increase risks?


St. Petersburg

13:30 14:00 0:30 Life-long immunization as a cancer control tool(supported by MSD)

Leyla Namazova- Baranova National Medical Research Center for Children's Health of the Ministry of Health of Russian Federation; I.M. Sechenov First Moscow State Medical University (Sechenov University); FSBEI Pirogov Russian National Research Medical University

Moscow

14:00 14:30 0:30 Scientific research on the spread and control of HPV-associated cancer(supported by MSD)

Anton Barchuk FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation; University of Tampere

St. Petersburg

14:30 15:00 0:30 Vaccination of cancer patients — a look at the Russian and international guidelines(supported by MSD)

Susanna Kharit FSFI Pediatric Research and Clinical Center for Infectious Diseases under the Federal Medical Biological Agency

St. Petersburg

15:00 15:30 0:30 Discussion15:30 16:00 0:30 Break16:00 18:30 “Speak louder, I can’t hear you”: who, how and why becomes a public expert in medicine (in collaboration with the Scientific Communication center of University

of Information Technologies, Mechanics and Optics)Moderator Aleksandra Borisova Association of communicators in the field

of science and educationSt. Petersburg

16:00 16:20 0:20 What data can be used to search for experts? Daniil Aleksandrov National Research University - Higher School of Economics; Laboratory of Sociology in Education and Science

St. Petersburg

16:20 16:40 0:20 New meeting place for a doctor and a patient — online

Olga Chernyak Social Movement «Cure Cancer» Moscow

16:40 17:00 0:20 How does the discussion about evidence-based medicine in the media develop?

Ekaterina Borozdina European University at St. Petersburg St. Petersburg

17:00 17:20 0:20 How does an evidence-based approach in medicine changes approaches to a clinic management?

Olga Vasilyeva Scandinavia Clinic St. Petersburg

17:20 17:40 0:20 How and where to search for medical experts during the coronavirus epidemic?

Elizaveta Babitskaya freelancer St. Petersburg

17:40 18:00 0:20 How can a doctor become an opinion leader? Elena Motova Clinic «Dawn» Moscow


9:00 19:05 Current oncohematology: bone marrow transplantation — targeted, cell and immunotherapy (section in memory of Professor Boris Afanasyev)9:00 9:40 Session 1. In the memory of Boris Afanasiev

Moderator Sergey Alekseev SBHI «Leningrad regional clinical oncology center»

St. Petersburg

Chair Lyudmila Zubarovskaya Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

9:00 9:30 0:30 Bone marrow transplantation — advances in treatment and future perspectives

Lyudmila Zubarovskaya Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

9:30 9:40 0:10 Discussion9:40 9:45 0:05 Break9:45 11:40 Session 2. Current therapy for Hodgkin lymphoma

Moderator Sergey Alekseev SBHI «Leningrad regional clinical oncology center»

St. Petersburg

Chair Natalia Mikhaylova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

9:45 10:05 0:20 Organization of care for patients with lymphomas Sergey Alekseev SBHI «Leningrad regional clinical oncology center»

St. Petersburg

10:05 10:25 0:20 Immunotherapy for Hodgkin lymphoma Larisa Filatova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:25 10:45 0:20 Predictors of response and overcoming resistance to classical Hodgkin lymphoma immunotherapy. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Kirill Lepik Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

10:45 11:00 0:15 Influence of unfavorable prognosis factors on the efficacy of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in patiens with recurrent and refractory forms of Hodgkin's lymphoma. Experience of Petrov Oncology NMRC

Yulia Oleynik FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:00 11:15 0:15 Allogeneic hematopoietic cell transplantation in patients with recurrent/refractory classical Hodgkin’s lymphoma. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Anastasia Beynarovich Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

26.06.2020

11:15 11:30 0:15 Optimization of nivolumab treatment in patients with recurrent/refractory classical Hodgkin’s lymphoma. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Lyudmila Fedorova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

11:30 11:40 0:10 Discussion11:40 11:45 0:05 Break11:45 13:40 Session 3. Current trends in therapy for Non-Hodgkin lymphomas

Moderator Kirill Lepik Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

Chair Natalia Mikhaylova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

11:45 12:05 0:20 What's new in the non-Hodgkin lymphomas treatment: targeted therapy, immunotherapy and bone marrow transplantation

Natalia Mikhaylova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

12:05 12:25 0:20 CD19 CAR-T therapy. Experience of the University of Hamburg TCM Clinic

Boris Fehse Cell and Gene Therapy Department, University of Hamburg Bone Marrow Transplant Clinic

Hamburg, Germany

12:25 12:45 0:20 Chemotherapy and hematopoietic stem cell transplantation in HIV patients with lymphomas

Marina Popova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

12:45 13:00 0:15 New protocols and drugs for aggressive B-cell Non Hodgkin lymphomas treatment. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Olesya Smykova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

13:00 13:15 0:15 HSCT in the T-cell lymphomas treatment. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Elena Lepik Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

13:15 13:30 0:15 Immunotherapy and bone marrow transplantation in case of primary CNS lymphoma. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Andrey Gavrilenko Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

13:30 13:40 0:10 Discussion13:40 13:55 0:15 Break13:55 15:25 Session 4. Current trends in therapy of children with hematological malignancies. Part 1

Moderator Anton Subora FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Lyudmila Zubarovskaya Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

13:55 14:15 0:20 20 years’ experience of varying intensity conditioning therapy at allogeneic hematopoietic stem cell transplantation in children (MAC vs RIC)

Anna Semenova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

14:15 14:30 0:15 Haplo-HSCT — efficacy in children with prognostically unfavorable AML and ALL variants

Olesya Paina Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

14:30 14:45 0:15 Recurrent/refractory B-ALL immunotherapy: allo-HSCT, monoclonal antibodies

Inna Markova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

14:45 15:00 0:15 Allogeneic hematopoietic stem cell transplantation in children with various myelodysplastic syndromes

Anna Osipova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

15:00 15:15 0:15 The use of hematopoietic stem cell haploidentical transplantation as a therapy for the initial implant failure in patients with non-malignant diseases

Tatiana Bykova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

15:15 15:25 0:10 Discussion15:25 15:30 0:05 Break15:30 17:15 Session 5.Current trends in therapy of children with hematological malignancies Part 2

Moderator Anton Subora FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Mikhail Maschan Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

15:30 15:50 0:20 CD19 CAR-T therapy in the refractory ALL treatment in children

Mikhail Maschan Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

15:50 16:05 0:15 Lymphomas in children. HSCT, immuno and targeted therapy

Andrey Kozlov Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

16:05 16:20 0:15 Current trends in pediatric solid tumors therapy Ilya Kazantsev Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

16:20 16:35 0:15 Allogeneic bone marrow transplantation in children with neuroblastoma. Experience of Petrov Oncology NMRC

Anton Subora FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

26.06.2020

16:35 16:50 0:15 HDCT efficacy for central nervous system tumors in children. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Hasmik Gevorgyan Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

16:50 17:05 0:15 Ewing sarcoma — the role of high-dose chemotherapy. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Tatiana Yukhta Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

17:05 17:15 0:10 Discussion17:15 17:20 0:05 Break17:20 19:05 Session 6. Maintenance therapy in oncohematology and HSCT

Moderator Marina Popova Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

Chair Nikolai Klimko North-western State Medical University named after I.I.Mechnikov

St. Petersburg

17:20 17:40 0:20 New guidelines for the mycoses diagnosis and treatment in hematologic patients

Nikolai Klimko North-western State Medical University named after I.I.Mechnikov

St. Petersburg

17:40 17:55 0:15 Influence of intestinal microbiota during chemotherapy and hematopoietic stem cell transplantation

Oleg Goloshchapov Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

17:55 18:10 0:15 Nutritional support in hematopoietic stem cell transplantation

Maksim Kucher Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

18:10 18:25 0:15 Invasive aspergillosis in patients with B-cell lymphomas. Experience of Petrov Oncology NMRC

Yulia Chudinovskikh FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

18:25 18:40 0:15 Infectious complications during immuno- and targeted therapy in patients with lymphomas. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Yulia Rogacheva Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg

18:40 18:55 0:15 Infectious deposition in patients with GVHD. Experience of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation

Aleksander Sinyaev Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation; Pavlov First St.Petersburg State Medical University

St. Petersburg


9:00 10:00 1:00 Pfizer symposiumMetastatic Breast Cancer and Germline BRCA Mutations - from testing to treatmentModerator Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg

09:00 09:05 0:05 Introduction. Expansion of opportunities of breast cancer treatment personalization


09:05 09:20 0:15 Germline BRCA Mutation - what is important to know and rememberIrina Kolyadina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

09:20 09:40 0:20 Talazoparib in modern treatment algorithm of HER2-negative mBC and Germline BRCA MutationsLarisa Bolotina P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

09:40 09:55 0:15 First multicenter experience with Talazoparib Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

09:55 10:00 0:05 Closing remarks Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg10:00 10:30 0:30 Break10:30 11:30 1:00 Johnson&Johnson symposium (simultaneous translation support)

Stapling devices differences : Engineering view on surgical devices qualityModerator Maria Anufrieva Johnson & Johnson Moscow

10:30 11:30 1:00 Stapling devices differences : Engineering view on surgical devices quality

Federico Bilotti Exclusive Consultant Johnson & Johnson, Mechanical Engineer

Rome, Italy

11:30 12:00 0:30 Break12:00 13:00 1:00 MSD symposium

Recent advances in immunotherapy: exploring optimal combinationsModerator Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

12:00 12:20 0:20 Pembrolizumab+chemotherapy combination for the treatment of the non-squamous NSCLC in 1st line: long-term results

Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:20 12:40 0:20 Inhibition of 2 mechanisms of carcinogenesis of RCC: turning theory into practice

Maria Volkova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:40 13:00 0:20 Chemo-immunotherapy: novel treatment approaches for advanced HNSCC in 1st line

Svetlana Kutukova St.-Petersburg City Oncology Clinic St. Petersburg

13:00 13:30 0:30 Break13:30 14:30 1:00 AstraZeneca symposium

Moderators Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


Moscow


Moscow

13:30 13:50 0:20 Mutations in BRCA 1/2 genes: high science or real clinical practice?


St. Petersburg

13:50 14:10 0:20 BRCA-associated ovarian cancer - is the disease receding?


Moscow

26.06.2020

14:10 14:30 0:20 BRCA-associated breast cancer - a special treatment for a special group of patients


Moscow

14:30 15:00 0:30 Break15:00 16:00 1:00 Lilly Pharma symposium

Following the rainbow (RAINBOW) - a renaissance of antiangiogenic therapy of the second line of gastrointestinal tumorsModerator

15:00 15:20 0:20 Antiangiogenic therapy of gastric cancer in the second line: current progress, unresolved issues and future directions


15:20 15:40 0:20 Unresolved issues of the choice of the second line of therapy for metastatic colorectal cancer

Mikhail Fedyanin FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

15:40 15:55 0:15 From registration studies to real clinical practice: experience with ramucirumab in St.-Petersburg City Oncology Clinic

Natalia Belyak St.-Petersburg City Oncology Clinic St. Petersburg

15:55 16:00 0:05 Discussion16:00 16:30 0:30 Break16:30 17:30 1:00 Bristol-Myers Squibb symposium (simultaneous translation support)

Double immunotherapy in the 1st line of treatment of non-small cell lung cancer Moderator Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

16:30 17:00 0:30 Prospects for double immunotherapy in the 1st line of treatment of non-small cell lung cancer

Solange Peters СHUV Lausanne University; ESMO Lausanne, Switzerland

17:00 17:30 0:30 The effectiveness of double immunotherapy NSCLC depending on the level of expression of PD-L1


Moscow

June 27

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

Stream № 1 (studio — Petrov NMRC)9:00 11:00 Melatonin in oncology: from experiment to clinic

Chair Vladimir Anisimov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:00 9:15 0:15 The use of melatonin in preventive oncoherontology

Irina Vinogradova Petrozavodsk State University Petrozavodsk

9:15 9:30 0:15 Chronobiological rationale for the use of melatonin in cancer patients treatment

Olga Blank FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

9:30 9:45 0:15 The role of melatonin in breast cancer patients

Mikhail Osipov SBHI «Leningrad regional clinical oncology center»

St. Petersburg

9:45 10:00 0:15 Melatonin and lung cancer: marker for target therapy

Igor Kvetnoy FSBI «St.Petersburg Research Institute of phthisiopulmonology» of the Ministry of Health of the Russian Federation; Saint Petersburg Institute of Bioregulation and Gerontology

St. Petersburg

10:00 10:15 0:15 Impact of melatonin on survival rates in prostate cancer patients after combined therapy

Gennadiy Zharinov FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

10:15 10:30 0:15 Correlation between geophysical anomaly impact during gestation and following tumor development in adults

Sergey Ivanov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:30 10:45 0:15 Melatonin and cancer: the closing remark Vladimir Anisimov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:45 11:00 0:15 Discussion11:00 11:30 0:30 Stream break11:30 13:40 SPOT: Talking basics

Chairs Galina Kireeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Evgenya Kharchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:30 11:35 0:05 Opening session Galina Kireeva, Evgenya Kharchenko11:35 11:55 0:20 Hallmarks of Cancer Vladimir Kushnarev FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

11:55 12:15 0:20 Clonal evolution in cancer Nikita Savelov Moscow city oncology hospital №62 Moscow12:15 12:35 0:20 Tumor microenvironment: composition,

principles and mechanisms of the development and how it works in lymphomas

Ilya Polyatskin FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:35 12:50 0:15 How to interpret Experimental studies In oncology

Galina Kireeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:50 13:05 0:15 Mechanisms of anticancer drugs Evgenya Kharchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:05 13:20 0:15 Doctors training innovative methods: the XXI century realities

Sergey Linnik Scientific Society «Medical Practice» Moscow

13:20 13:40 0:20 Discussion13:40 14:05 0:25 Stream break

Stream №2 (studio — Pribaltiyskaya)9:00 17:45 Fundamental aspects of cancer immunology9:00 11:05 Session 1. Fundamental issues of cancer immunology

Moderators Irina Baldueva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Andrey Simbirtsev FSUE State Research Institute of Ultrapure Biologicals of the Federal medical-biological agency

St. Petersburg

9:00 9:10 0:10 Opening session9:10 9:30 0:20 Predictive and prognostic factors of

systemic immunity in case of breast cancer with a triple negative phenotype

Zaira Kadagidze FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

9:30 9:50 0:20 Promising directions of research for the next 10 years

Karine Sargsyan Medical University of Graz · Biobank Graz, Austria

9:50 10:10 0:20 Cytokines in immunopathogenesis and cancer treatment

Andrey Simbirtsev FSUE State Research Institute of Ultrapure Biologicals of the Federal medical-biological agency

St. Petersburg

10:10 10:30 0:20 Antitumor chemotherapy and the immune system: different relationship aspects

Nadezhda Cherdyntseva Tomsk National Research Medical Center of the Russian Academy of Science

Tomsk

10:30 10:50 0:20 Cellular and subcellular interactions visualization in immunological studies

Igor Kudryavtsev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:50 11:05 0:15 Discussion

11:05 11:10 0:05 Break11:10 15:20 Session 2. National research in cancer immunology

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

11:10 11:30 0:20 Three targeted therapy directions for PRAME-expressing diseases

Vsevolod Misyurin FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

11:30 11:50 0:20 Genetic engineering modifications of lymphocytes for malignant tumors immunotherapy

Sergey Larin Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

11:50 12:10 0:20 Development of a biomedical cell product — antiHER2 CAR-T-NK cells for solid tumors treatment.

Mikhail Kiselevsky FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:10 12:30 0:20 Use of immunological support technology for cancer patients in clinical practice

Aleksander Borisov Research Institute for Medical Problems in the North - Division of Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch of the RAS»

Krasnoyarsk

12:30 12:50 0:20 Is there an immune response to a tumor tissue interstitial ablation?


St. Petersburg

12:50 13:00 0:10 Discussion13:00 13:50 0:50 Break13:50 14:10 0:20 Study of immune status in patients with

metatstatic solid tumorsAnton Zozulya FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

14:10 14:30 0:20 T-regulatory cells influence on the formation of the dendritic cells phenotype in patients with kidney cancer

Andrey Savchenko Research Institute for Medical Problems in the North - Division of Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch of the RAS»

Krasnoyarsk

14:30 14:50 0:20 Creating personalized tumor-based cell systems to optimize aggressive solid tumors drug treatment

Elizaveta Prosekina FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:50 15:10 0:20 An experimental study of the oncolytic effect of a new unclassified group of Reoviridae family human rotaviruses

Elena Zlatnik National Medical Research Centre for Oncology; FBUN «Rostov Research Institute of Microbiology and Parasitology» of Rospotrebnadzor

Rostov-on-Don

15:10 15:20 0:10 Discussion

15:20 15:25 0:05 Break15:25 17:45 Session 3. Perspective trends in the development of cancer immunology15:25 15:45 0:20 Development of humanized antibodies

against PRAME antigen for cancer treatment

Andrey Misyurin GeneTechnology LLC Moscow

15:45 16:05 0:20 Experimental laboratory and clinical examination of cancer-specific DNA vaccines

Vitali Alexeev Sidney Kimmel Medical College Philadelphia, USA

16:05 16:25 0:20 Immunological microenvironment of tumor cells with stem phenotype in the setting of gastric cancer

Aleksander Sagakyants National Medical Research Centre for Oncology

Rostov-on-Don

16:25 16:45 0:20 The use of anti-GD2 antibodies in children with high-risk neuroblastoma: experience of the Oncology NMRC named after N. N. Petrov

Natalia Faseeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:45 17:05 0:20 Mesenchymal stem cells in treatment of cancer patients with COVID-19-pneumonia

Irina Baldueva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

17:05 17:25 0:20 Theses review Aleksey Novik FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


8:40 17:50 VI M.L. Gershanovich Conference “Personalized therapy for patients with gastrointestinal cancer: from science to practice” (interactive voting)8:40 11:00 Session 1. Personalized therapy for gastric cancer patients (simultaneous translation support)


St. Petersburg

Gulfiya Teletaeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Lyubov Vladimirova National Medical Research Centre for Oncology

Rostov-on-Don

8:40 9:00 0:20 Focus on the stomach cancer. What do we know today?


St. Petersburg

9:00 9:20 0:20 Perioperative chemotherapy in gastric cancer patients (interactive voting)

Nadezhda Brish FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:20 9:40 0:20 HER2+ targeted therapy for locally advanced gastric cancer and cardioesophageal junction (interactive voting)

Inna Avramenko St.-Petersburg City Oncology Clinic St. Petersburg

9:40 10:00 0:20 Immunotherapy in esophagial and gastric cancer: indications

Lyubov Vladimirova National Medical Research Centre for Oncology

Rostov-on-Don

10:00 10:20 0:20 Second line targeted therapy in metastatic gastric cancer (interactive voting)

Natalia Belyak St.-Petersburg City Oncology Clinic St. Petersburg

10:20 10:50 0:30 Modern approaches to treatment of metastatic gastric cancer beyond the second line (interactive voting)(supported by Servier)

Elizabeth Smyth Cambridge University Hospital, NHS Foundation Trust

Cambridge, United Kingdom

10:50 11:00 0:10 Discussion

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

11:00 11:05 0:05 Break11:05 13:05 Session 2. Personalized therapy in colorecral cancer patients (simultaneous translation support)


St. Petersburg


St. Petersburg

Chairs Lyubov Vladimirova National Medical Research Centre for Oncology

Rostov-on-Don


Moscow


Moscow

11:05 11:25 0:20 Molecular analysis and grading of gastrointestinal tumors — do we need it now?

Maksim Filipenko FSBIS «Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences»

Novosibirsk

11:25 11:55 0:30 First-line drug therapy selection strategy for metastatic colorectal cancer treatment (interactive voting)

Mario Scartozzi University of Cagliari University Hospital Cagliari, Italy

11:55 12:10 0:15 Second line antiangiogenic therapy: which options to prefer? (interactive voting)(supported by Sanofi)

Albina Zhabina SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

12:10 12:25 0:15 Metastatic CRC with BRAF mutation — how to treat? (interactive voting)


Moscow

12:25 12:40 0:15 CRC with oligometastasis: is there a chance for a cure? Clinical oncologist perspective


Moscow

12:40 12:55 0:15 CRC with oligometastasis: is there a chance for a cure? Surgical oncologist perspective

Andrey Damanskiy FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:55 13:05 0:10 Discussion13:05 13:10 0:05 Break13:10 14:40 Session 3. Personalized therapy for gastrointestinal neuroendocrine tumors


St. Petersburg

Chairs Grigoriy Raskin FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

Vera Gorbunova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

13:10 13:30 0:20 Problems in gastrointestinal tract neuroendocrine tumors (NET) diagnosis

Grigoriy Raskin FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

13:30 13:50 0:20 PET-CT with different radiopharmaceuticals in n NET diagnosis

Anna Ivanova FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

13:50 14:20 0:30 New neuroendocrine tumors guidelines review

Vera Gorbunova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:20 14:40 0:20 Discussion14:40 14:45 0:05 Break14:45 16:05 Session 4. Personalized therapy in pancreatic cancer patients


St. Petersburg

Chair Ilya Pokataev SBHI «City clinical oncological hospital №1 of the Moscow City Department of Health»

Moscow

14:45 15:05 0:20 What do we know about BRCA-associated pancreatic cancer (interactive voting)


Moscow

15:05 15:25 0:20 Pancreatic cancer chemotherapy: are we standing still or moving forward? (interactive voting)(supported by Sanofi)

Ilya Pokataev SBHI «City clinical oncological hospital №1 of the Moscow City Department of Health»

Moscow

15:25 15:45 0:20 Is there a place for pancreatic cancer immunotherapy (interactive voting)?

Anastasia Danilova Moscow city oncology hospital №62 Moscow

15:45 16:05 0:20 Discussion16:05 16:10 0:05 Break16:10 17:50 Session 5. Personalized therapy in hepatobiliary and cholangiobiliary tumors patients treatment


St. Petersburg

Chair Valeriy Breder FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

16:10 16:30 0:20 Hepatocellular cancer: issues of diagnosis and treatment in Kazakhstan

Dilyara Kaydarova Kazakh Institute of Oncology and Radiology

Kazakhstan

16:30 16:50 0:20 Hepatocellular cancer: issues of diagnosis and treatment in Armenia

Aykui Geokchyan Oncology Erebuni medical center Armenia

16:50 17:10 0:20 Inoperable hepatocellular cancer: what determines the first-line therapy choice? (supported by Eisai Co., Ltd.)

Valeriy Breder FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

17:10 17:30 0:20 Treatment of biliary tract tumors from clinical oncologist perspective

Evgeny Ledin «Medsi» clinic Moscow


9:30 15:10 Tumor morphology9:30 12:00 Session 1. Digital pathology (simultaneous translation support)

Moderator Maria Urezkova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Anna Artemyeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Andrew Janowczyk Case Western Reserve University (CWRU)

Cleveland, USA

Asel Kudaybergenova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:30 10:00 0:30 Place of digital pathology in the work of a pathologist


St. Petersburg

10:00 10:20 0:20 Modern histological scanners: capabilities and limitations (comparison of characteristics of some available systems)

Ekaterina Artemyeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:20 10:50 0:30 Computatonal pathology: Towards precision medicine

Andrew Janowczyk Case Western Reserve University (CWRU)

Cleveland, USA

10:50 11:10 0:20 The use of digital image analysis methods to increase reproducibility of the nuclear immunohistochemical markers assessment (through the example of breast cancer)

Vladimir Kushnarev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:10 11:30 0:20 Using digital pathology devices to evaluate a FISH study results. Experience of N. N. Petrov

Maria Urezkova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:30 12:00 0:30 Discussion12:00 12:30 0:30 Break12:30 15:10 Session 2. Changes in the classification of tumors, reflected in a pathologist daily practice

Moderator Tatiana Golovanova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chair Anna Artemyeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:30 12:50 0:20 WHO 2020 breast tumors: overview Dina Chuglova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:50 13:10 0:20 WHO 2019 digestive system tumors: colorectal cancer

Olga Ivko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:10 13:30 0:20 WHO 2019 digestive system tumors: colon and rectum serration

Anastasia Muravtseva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:30 13:50 0:20 WHO 2019 digestive system tumors: mucous appendix tumors, morphological diagnosis difficulties

Olga Ivko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:50 14:10 0:20 WHO 2019 digestive system tumors: neuroendocrine tumors

Tatiana Golovanova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:10 14:30 0:20 WHO 2019 digestive system tumors: mesenchymal tumors

Artem Gogolev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:30 14:50 0:20 WHO 2020 soft tissue and bone tumors: review


St. Petersburg

14:50 15:10 0:20 Discussion15:10 16:00 0:50 Break16:00 17:00 1:00 BioVitrum symposium (simultaneous translation support)

Experience of digitization in Pathology, from research to full clinical implementation Moderator Pavel Suchilin LLC BioVitrum St. Petersburg

16:00 16:50 0:50 Experience of digitization in Pathology, from research to full clinical implementation

Elin Kindberg Sectra Imaging IT solutions Linkoping Linkoping, Sweden

16:50 17:00 0:10 Questions and answersStream №5 (studio — Pribaltiyskaya)

9:00 10:00 1:00 Roche symposium New season of personalized therapy for patients with NSCLC and NER2-positive breast cancerModerator Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

9:00 9:30 0:30 Algorithm for managing patients with advanced NSCLC: an ideal scenario in 2020


Moscow

9:30 10:00 0:30 How to combine standards of care and a personalized approach in early HER2-positive breast cancer?

Irina Kolyadina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

10:00 10:30 0:30 Break10:30 11:30 1:00 Roche symposium

The cipher for immunotherapy is now in your hands: unique combinations in the 1st line of immunotherapy for HCC, UС and TNBC Moderator Valeriy Breder FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

10:30 10:50 0:20 Decrypting patients with TNBC: how to choose effective combination with innovative therapy


Moscow

10:50 11:10 0:20 New HCC treatment options: unique code found

Valeriy Breder FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

11:10 11:30 0:20 Successful decryption of UCFirst-line urothelial cancer breakthrough


Moscow

11:30 12:00 0:30 Break12:00 19:10 Bone tumors and soft tissues sarcomas12:00 14:25 Session 1. Soft tissue sarcomas (simultaneous translation support)

Moderator Georgiy Gafton FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Renato Covello National Cancer Institute "Regina Elena" of Rome

Rome, Italy

Aleksander Fedenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia; FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Mamed Aliev FSBI NMRRC of the Ministry of Health of Russia

Moscow


St. Petersburg

12:00 12:10 0:10 Opening session12:10 12:25 0:15 The role of pathologist. in the

multidisciplinary team workIgnat Schwartz Chaim Sheba Medical Center, Tel-

Hashomer HospitalTel Aviv, Israel

12:25 12:40 0:15 The use of controlled negative pressure systems during the postoperative period in patients with bone and soft tissue tumors

Ivan Gafton FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:40 12:55 0:15 Soft tissue sarcomas: WHO 2020 classification, what’s new?

Renato Covello National Cancer Institute "Regina Elena" of Rome

Rome, Italy

12:55 13:15 0:20 Discussion13:15 13:20 0:05 Break13:20 13:35 0:15 Role of systemic therapy in the soft tissue

sarcoma treatmentDilorom Latipova FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

13:35 13:50 0:15 Perspective areas of soft tissue sarcomas radiotherapy

Maria Ebert FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:50 14:05 0:15 Desmoid. "Look&stay" tactic Artur Bokhyan FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:05 14:25 0:20 Discussion14:25 15:00 0:35 Break15:00 19:10 Session 2. Bone tumours (simultaneous translation support)

Moderator Georgiy Gafton FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Valeriy Teplyakov FSBI Russian Scientific Center of Roentgenoradiology (RSCRR) of the Ministry of Healthcare of the Russian Federation

Moscow

Sergey Zaretskiy N.N. Alexandrov National Cancer Centre of Belarus

Minsk, Republic of Belarus

Nogah Haramati Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, NY USA

New York, USA


St. Petersburg

15:00 15:10 0:10 Opening session15:10 15:25 0:15 Tumors of the Temporomandibular Joint

RegionNogah Haramati Albert Einstein College of Medicine &

Montefiore Medical Center, Bronx, NY USA

New York, USA

Aleksandra Fedorova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

15:25 15:40 0:15 Bone tumors: WHO 2020 classification, what’s new?

Dina Chuglova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:40 15:55 0:15 To be announced Valeriy Teplyakov FSBI Russian Scientific Center of Roentgenoradiology (RSCRR) of the Ministry of Healthcare of the Russian Federation

Moscow

15:55 16:10 0:15 3D-printing technologies in reconstruction of post-resection defects in patients with musculoskeletal system tumors


St. Petersburg

16:10 16:30 0:20 Discussion16:30 16:35 0:05 Break16:35 16:50 0:15 Reasons for revision arthroplasty in cancer

patientsAleksey Starodubtsev A. Tsyb Medical Radiological Research

Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Обнинск

16:50 17:05 0:15 Influence of the sacrum chordomas morphology on the long-term results of treatment. Multiple factor analysis of 68 cases

Irina Bulycheva FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Nikita Babkin


Moscow

17:05 17:20 0:15 Computer and additive technologies in the treatment of patients with pelvic bone tumors

Evgeny Sushentsov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

17:20 17:35 0:15 Long bones tumors surgical treatment with reconstructive plastic stage

Ildar Safin Tatarstan Regional Clinical Cancer Center Kazan

17:35 17:55 0:20 Discussion17:55 18:00 0:05 Break18:00 18:15 0:15 Pelvic resections in children and

adolescentsNikolai Bolshakov Dmitry Rogachev National Medical

Research Center Of Pediatric Hematology, Oncology and Immunology

Moscow

18:15 18:30 0:15 New approaches to the extensive bone defects replacement in cancer patients

Aleksander Zheravin FSBI «E.N. Meshalkin NMRC» of the Ministry of Healthcare of the Russian Federation

Novosibirsk

18:30 18:45 0:15 Surgical treatment tactics for spinal metastatic lesions

Sergey Zaretskiy N.N. Alexandrov National Cancer Centre of Belarus

Minsk, Republic of Belarus


Stream №6 (studio — Pribaltiyskaya)9:00 13:05 Current immuno-oncology


St. Petersburg

Chairs Galina Kharkevich FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg9:00 9:10 0:10 Opening session9:10 9:30 0:20 Immunotherapy in the COVID-19

pandemic context: pros and consIrina Koroleva University «Reaviz» Samara

9:30 9:50 0:20 Predictors of response to immunotherapy, any changes?

Nikita Savelov Moscow city oncology hospital №62 Moscow

9:50 10:10 0:20 NSCLC immunotherapy Sergey Orlov Pavlov First St.Petersburg State Medical University

St. Petersburg

10:10 10:30 0:20 New advances in the treatment of SCLC (supported by Roche)


St. Petersburg

10:30 10:50 0:20 Discussion10:50 10:55 0:05 Break10:55 11:15 0:20 Prospects for melanoma immunotherapy Galina Kharkevich FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

11:15 11:35 0:20 Kidney cancer: first line therapy Ilya Timofeev Hadassah Medical Moscow Moscow11:35 11:55 0:20 Combined therapy: pros and cons Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg11:55 12:15 0:20 Perspectives of neoadjuvant

immunotherapyFedor Moiseenko SBHI «St. Petersburg Clinical Scientific

and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

12:15 12:35 0:20 Controversies in immunotherapy Aleksey Novik FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:35 12:55 0:20 Questions, discussion12:55 13:05 0:10 Closing session13:05 14:00 0:55 Stream break14:00 17:55 Complications of anticancer therapy


St. Petersburg

Chairs Anna Semenova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution CityChairs

Galina Kharkevich FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

14:00 14:10 0:10 Opening session14:10 14:30 0:20 Immune-related adverse events: what's

new?Aleksey Novik FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

14:30 14:50 0:20 Complications of drug therapy in the COVID-19 pandemic context

Ivan Rykov St. Petersburg Clinical Hospital of the Russian Academy of Sciences

St. Petersburg

14:50 15:10 0:20 Rare immune-related adverse events Natalia Petenko FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

15:10 15:30 0:20 Immune-related GI adverse events Dilorom Latipova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:30 15:50 0:20 Immune-related endocrinopathies Nikita Volkov SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

15:50 16:10 0:20 Discussion16:10 16:15 0:05 Break16:15 16:35 0:20 Immune-related skin and lung toxicity Anna Semenova FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

16:35 16:55 0:20 Complications of combined therapy Svetlana Kutukova St.-Petersburg City Oncology Clinic St. Petersburg16:55 17:15 0:20 Cancer and COVID19: and what about the

cardiovascular system?Marina Balluzek St. Petersburg Clinical Hospital of the

Russian Academy of SciencesSt. Petersburg

17:15 17:35 0:20 Clinical cases (supported by Roche)

Natalia Zhukova St.-Petersburg City Oncology Clinic St. Petersburg


8:30 10:40 RAОМ (Russian association of oncological mammology) symposiumModerator Ruslan Paltuev FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

8:30 9:00 0:30 The most significant events in the breast cancer diagnosis and treatment over the past 10 years

Vladimir Semiglazov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:00 9:20 0:20 Gold standard 2020. Breast cancer pathology and IHC evaluation

Asel Kudaybergenova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:20 9:40 0:20 Gold standard 2020. Breast cancer treatment

Sergey Portnoy FSBI «Clinical Hospital» Moscow

9:40 10:00 0:20 Gold standard 2020. Breast cancer radiation therapy

Oksana Trofimova FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

10:00 10:20 0:20 Gold standard 2020. Breast cancer systemic therapy


St. Petersburg

10:20 10:40 0:20 Discussion10:40 11:00 0:20 Stream break11:00 19:15 Clinical trial — science, international experience and investment in the medicine of future. Section in the memory of Mikhail Lichinitser 11:00 12:50 Session 1. Market conditions and new clinical research paradigms

Moderator Artem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Andrey Kaprin FSBI NMRRC of the Ministry of Health of Russia

Moscow

Anton Seleznev BIOCAD MoscowDmitry Rozhdestvenskiy Eurasian Economic Commission MoscowAleksey Malikov FSBI Almazov National Medical research


St. Petersburg

11:00 11:20 0:20 Opportunities for increasing health benefits within the existing infrastructure of IMCTs in Russia

Aleksander Bliev Moscow

11:20 11:40 0:20 Adaptive trial design Andrey Krendyukov VP, Head Medical Affairs Heidelberg, Germany

11:40 12:00 0:20 Master Protocols: a new approach to conducting clinical trials

Vladimir Bogin St. John Medical Center, Cromos Pharma, Batu Biologics

Potland, USA

12:00 12:20 0:20 Regulation of early stages of drug research in the law of the Union: requirements, volumes and procedures

Dmitry Rozhdestvenskiy Eurasian Economic Commission Moscow

12:20 12:40 0:20 Cancellation of accreditation of clinics for clinical trial. What's next?

Konstantin Gudkov AstraZeneca Moscow

12:40 12:50 0:10 Discussion12:50 12:55 0:05 Break12:55 13:55 Session 2. Digital freedom in clinical research

Moderator Maksim Kulunchakov OST St. PetersburgChairs Olga Vostrikova International Patient Union Moscow

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

ChairsKonstantin Zakharov Eco-Safety Research Center St. PetersburgAnton Pavlyukov Skolkovo Foundation MoscowArtem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

12:55 13:10 0:15 ClinLine.ru: how information aggregation sites develop CS markets in the world

Daria Ivanova IPHARMA LLC Moscow

13:10 13:25 0:15 Present and future of the eClinicalTrials segment

Mikhail Getman Enrollmi.ru LLC Moscow

13:25 13:40 0:15 MIKA — selection of clinical trials for patients

Sheyla Dzhalilova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:40 13:55 0:15 Discussion13:55 14:00 0:05 Break14:00 15:25 Session 3. A new generation of researchers

Moderator Anton Krutov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Vladimir Andrianov I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow

Ekaterina Kholodkova Synergy Research Group LLC MoscowArtem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

14:00 14:20 0:20 Psychological issues of signing an informed consent

Kristina Kondratieva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:20 14:30 0:10 Questions from a young researcher Karina Khidishchyan FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:30 14:40 0:10 Clinical trials budgeting Anton Krutov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:40 14:50 0:10 One-stop clinical trial management Andrey Chicherin SBHI «Leningrad regional clinical oncology center»

St. Petersburg

14:50 15:00 0:10 Ksenia Konovalova SBHI «Leningrad regional clinical oncology center»

St. Petersburg

15:00 15:10 0:10 Support programs for young scientists, on the example of Sechenov University

Vladimir Andrianov I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow

15:10 15:25 0:15 Discussion15:25 15:30 0:05 Break15:30 17:10 Session 4. International experience

Moderator Maria Zaytseva FSBIS Institute of Toxicology of Federal Medical-Biological Agency

St. Petersburg

Chairs Sergey Simeniv X7 Company St. PetersburgArtem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Evgeny Rogov Moscow15:30 15:50 0:20 Eastern European and CIS countries as a

potential clinical trial arena for small and medium-sized biotechnology companies

Pavel Tyan Advanced Clinical Frankfurt, Germany

15:50 16:10 0:20 International clinical trials organization experience by a Russian sponsor company

Ekaterina Dokukina BIOCAD St. Petersburg

16:10 16:30 0:20 How to set an efficient Inspection Readiness Program for pre-approval inspections

Natalia Buchneva UCB BioSciences GmbH St. Petersburg

16:30 16:50 0:20 Experience in participating in international inspections of research centres

Evgeny Rogov Moscow

16:50 17:10 0:20 Discussion17:10 17:15 0:05 Break17:15 19:40 Session 5. AIPM. Panel discussion

Moderator Ksenia Teplova-Bareysha Bayer Company MoscowChairs Artem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Aleksander Fedenko P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia; FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow


Moscow

Ruslan Paltuev FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

Chairs

Andrey Mescheryakov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

Aleksey Vasilyev Merck LLC St. Petersburg17:15 17:40 0:25 Clinical trials in the COVID-19 pandemic

context. Russian and international experience

Tatiana Petrova Novartis Pharma LLC St. Petersburg17:40 18:10 0:30 Open discussion Sergey Dubrovin Pfizer Inc Moscow

Olga Melnik Novartis Pharma LLC MoscowAleksander Vasilyev Clinical Hospital «Russian Railways -

Medicine»St. Petersburg

Artem Poltoratskiy FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg18:10 18:30 0:20 Audit in a center: fear not rejoice. How to

pass an audit successfully?Anna Dontsenko GlaxoSmithKline LLC Trading Moscow

18:30 18:50 0:20 How should sponsors develop clinical centers and how do centers develop sponsors?


Moscow

Yulia Nezametdinova Компания Astra Zeneca Moscow18:50 19:15 0:25 Open discussion Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

Yulia Nezametdinova Astra Zeneca MoscowAleksander Andreev Representation of «Servier Laboratory» MoscowSvetlana Kutukova St.-Petersburg City Oncology Clinic St. PetersburgRashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg


10:30 11:30 1:00 Boehringer Ingelheim symposiumNon-small cell lung cancer in portraits and faces: modern approaches to therapyModerator Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of


Moscow

10:30 10:34 0:04

Openning Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

10:34 10:52 0:18

Role of EGFR TKI in the treatment of squamous cell lung cancer


St. Petersburg

10:52 11:02 0:10Afatinib as treatment option for squamous cell lung cancer. A clinical case

Aynur Nasretdinov City oncological clinic № 2 Ufa

11:02 11:20 0:18

Antiangiogenic strategy for therapy of non-squamous NSCLC in the era of immunotherapy


Moscow

11:20 11:30 0:10Nintedanib as treatment option for non-squamous NSCLC. A clinical case

Anna Tarasova Samara regional oncological hospital Samara

11:30 12:00 0:30 Break12:00 13:00 1:00 Bristol-Myers Squibb symposium

Double immunotherapy - a new step in extending of lifeModerator Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

12:00 12:12 0:12

Metastatic melanoma - is one line of therapy enough?

Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:12 12:24 0:12Double immunotherapy in oncourology - a new breakthrough in the fight for life


12:24 12:36 0:12

Gastrointestinal tumors - present and future

Aleksey Tryakin FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

12:36 12:48 0:12

Non-small cell lung cancer - double strike at a target


St. Petersburg

12:48 13:00 0:12 Discussion13:00 13:30 0:30 Break13:30 14:30 1:00 AstraZeneca symposium

Moderator Konstantin Laktionov FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

On the wave of success: a combination of CLT and immunotherapy betting locally advanced NSCLC


Moscow

Conquering the elements: immunotherapy of advanced small cell lung cancer

Alexey Smolin

Unknown shores: targeted therapy for resectable NSCLC with mutations in the EGFR gene


St. Petersburg

14:30 15:00 0:30 Break15:00 16:00 1:00 Merck symposium

Moderator Fedor Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

27.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

15:00 15:02 0:02

Sympsium opening Fedor Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

15:02 15:22 0:20

Cytoreduction as a guarantee of success of a significant increase in the life expectancy of patients with mCRC

Mikhail Ter-Ovanesov SBHI «City clinical hospital №40» of the Moscow City Department of Health

Moscow

15:22 15:30 0:08 Questions and answers

15:30 15:50 0:20

Individual approach in choosing first and subsequent lines of drug therapy for mCRC


Moscow

15:50 15:58 0:08 Questions and answers

15:58 16:00 0:02

Sympsium closure Fedor Moiseenko SBHI «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)»

St. Petersburg

16:00 16:30 0:30 Break16:30 17:30 1:00 Pfizer symposium

Sequential drug therapy for metastatic kidney cancerModerator Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Co-moderator Rashida Orlova St.-Petersburg City Oncology Clinic St. Petersburg

16:30 16:40 0:10Targeted therapy of mRCC in the first line from the clinical guidelines perspective

Ilya Timofeev Kidney Cancer Research Bureau Moscow

16:40 16:50 0:10

What has changed in the treatment standards for mRCC?


St. Petersburg

16:50 17:00 0:10Choice of 2nd line therapy for metastatic renal cell carcinoma


17:00 17:10 0:10Choice of treatment in a patient with mRCC- analysis of the clinical case

Timur Andabekov AV Medical Group St. Petersburg

June 28

28.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

Stream № 1 (studio — Petrov NMRC)9:00 10:30 A successful doctor

09.00 9:45 Session 1. Personal branding for doctors. How to create it?9:00 9:30 0:30 How to Build Your Personal Brand and

ReputationEvgenya Kharchenko FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

9:30 9:45 0:15 Discussion9:45 10:30 Session 2. Social media promotion tools 9:45 10:15 0:30 Creating your personal brand using social media Anastasia Lebedkina Moscow

10:15 10:30 0:15 Discussion10:30 11:00 0:30 Stream break11:00 14:35 Germ cell tumors. What are the standards in non-typical cases?


St. Petersburg

Chairs Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


Moscow

11:00 11:20 0:20 Вad dancers time Aleksander Nosov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:20 13:10 What should we do in rear clinical cases?11:20 11:40 0:20 Extragonadal germ cell tumors Mikhail Fedyanin FSBI «N.N. Blokhin NMRC of oncology»

of the Ministry of Healthcare of the Russian Federation

Moscow

11:40 11:55 0:15 Experience of N. N. Petrov NMRC of oncology Svetlana Protsenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:55 12:10 0:15 Experience of N. N. Petrov NMRC of oncology Evgeny Levchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:10 12:30 0:20 Primary intracranial germ cell tumors Gulfiya Teletaeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:30 12:50 0:20 Advanced germ cell tumors: how to proceed? Anna Semenova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

12:50 13:10 0:20 Discussion13:10 13:15 0:05 Break13:15 13:15 Clinical cases13:15 13:30 0:15 Сlinical case 1 Dilorom Latipova FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

13:30 13:45 0:15 Сlinical case 2 Maria Berkut FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:45 14:05 0:20 MicroRNA analysis in patients with germ cell tumors

Anastasia Malek FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg


Stream №2 (studio — Pribaltiyskaya)10:00 13:00 Session of patients organisations10:00 11:15 Session 1. Nonprofit cancer patients organisations: maintainig sustainability in unstable times


St. Petersburg

Chairs Oksana Moldovanova National Women's Health Support Fund MoscowKuzmenko Alena Unity Cancer Patient Care Community

MovementMoscow

10:00 10:25 0:25 Steps towards financial stability of NPOs: private sources fundraising strategy

Irina Menshenina Fundraiser Association Moscow

10:25 10:50 0:25 Negative content. How to talk simple about complex things

Anastasia Kaflanova Leukemia Foundation Moscow

10:50 11:15 0:25 Development of an NPO leader personal brand Inga Korchagina National Research University - Higher School of Economics

Moscow

11:15 11:20 0:05 Break11:20 13:00 Session 2. Patient session of Transregional non-commercial institution “Hello!” — cancer patients association Financing sources of state guarantees

for cancer patientsModerator Tatiana Semiglazova FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Chair Irina Borovova Cancer Patient Association «Hello!» Moscow11:20 11:30 0:10 Opening speech Irina Borovova Cancer Patient Association «Hello!» Moscow

28.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

11:30 12:00 0:30 Financing sources of state guarantees for cancer patients. Answers to questions from the Federal insurance Fund expert

Olga Tsareva Federal Compulsory Health Insurance Fund

Moscow

12:00 12:30 0:30 Financing sources of state guarantees for cancer patients. Answers to questions from the Federal sociomedical expertising bureau expert

Lyudmila Naumenko FSBI «Federal Bureau of Medico-Social Expertise» of the Ministry of Labour

Moscow

12:30 13:00 0:30 Discussion13:00 13:10 0:10 Break13:10 14:50 Current and future tasks for patients organisations in collaboration with the medical community


St. Petersburg

Chairs Marina Rumyantseva St. PetersburgNikolai Dronov Transregional social movement

«Movement Against Cancer»Moscow

13:10 13:25 0:15 Current and future tasks for patients organisations in the context of national cancer care strategy

Nikolai Dronov Transregional social movement «Movement Against Cancer»

Moscow

13:25 13:40 0:15 Current legal problems of an NPO founder and possible solutions

Elena Kadushkina Social project «About Life» St. Petersburg

13:40 13:55 0:15 "ThinkPinkEurope" — global initiative to support breast cancer patients

Evgenya Kharchenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:55 14:10 0:15 Raising public cancer prevention awareness Lidiya Chashina Kaliningrad regional public organization «Social and psychological support for women with cancer «Vita»

Kaliningrad

14:10 14:25 0:15 Volunteering: a self-developing organization Yulia Ivashkevich Autonomous non-commercial organization «We are together – Bez Berghe»

Kazan

14:25 14:40 0:15 NPOs and medical institutions: a common information area

Irina Ctolyarova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

14:40 14:50 0:10 Discussion14:50 14:55 0:05 Break14:55 18:40 What an cancer patient should know?


St. Petersburg

Chairs Elena Tkachenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Olga Chernyak Social Movement «Cure Cancer» Moscow14:55 15:10 0:15 A bone marrow transplantation is scheduled for a

cancer patient, what’s nextAnton Subora FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

15:10 15:25 0:15 Basic rules of chemotherapy: before, during and after

Elena Tkachenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:25 15:40 0:15 Doctor-patient communication as a tool to prevent and manage therapy side effects

Anastasia Danilova Moscow city oncology hospital №62 Moscow

15:40 15:55 0:15 A patient gerontological profile: does age affect tolerability of anticancer therapy and treatment outcomes?

Yuli Alekseeva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

15:55 16:10 0:15 Managing hair loss during chemotherapy Veronika Klimenko FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:10 16:25 0:15 PET/CT with various radiopharmaceuticals: what is it, to whom is it to be prescribed and why?

Anna Ivanova FSBI «A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies» of the Ministry of Health of the Russian Federation

St. Petersburg

16:25 16:40 0:15 Rehabilitation of patients with urinary incontinence after surgery for urologic cancers

Oleg Zaozersky FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

16:40 16:55 0:15 Cancer and pregnancy Anastasia Parokonnaya FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation; FSBI «National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov»

Moscow

16:55 17:10 0:15 Temporary procedure for recognizing a person as disabled during anti-epidemic measures in 2020

Elena Karol General Bureau of Medico-Social Expertise of the Ministry of Labour

St. Petersburg

17:10 17:25 0:15 Telemedicine - improving access to second opinion

Anna Malkova FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

17:25 17:40 0:15 Psychologist help to cancer patient Olga Yuskevich-Merg Autonomous non-commercial organization «We are together – Bez Berghe»

Kazan

17:40 17:55 0:15 Cancer recurrence fear — how to live a normal life after treatment

Evgenya Ananyeva Moscow

17:55 18:10 0:15 International clinical guidelines for cancer patients Mikhail Laskov Dr. Laskov Clinic Moscow

18:10 18:25 0:15 Answers to the most common questions a patient asks a clinical oncologist during consultation


St. Petersburg

28.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

18:25 18:40 0:15 Answers to questionsStream №3 (studio — Pribaltiyskaya)

9:30 15:15 Conference on fundamental oncology “Peter’s Readings” (Young scientists school) (supported by RSF: grant No. 17-75-30027) Moderator Evgeny Imyanitov FSBI «N.N. Petrov NMRC of oncology» of


St. Petersburg

Chair Ekaterina Kuligina FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

9:30 11:00 Session 19:30 10:00 0:30 Non-identity of hormonal and metabolic factors

associations with the risk of developing major noncommunicable diseases (NCDs): tumors of hormone-dependent tissues in comparison with cardiovascular and cerebrovascular pathologies; approaches to the reasons clarification

Lev Bershteyn FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:00 10:20 0:20 Predictive biomarkers of the chemoradiotherapy effectiveness in patients with gastrointestinal cancer

Sergey Ivanov FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:20 10:35 0:15 Value of hyperexpression of P-glycoprotein for formation of resistance to proteasome inhibitor of bortezomib

Lidiya Laletina FSBI «N.N. Blokhin NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

Moscow

10:35 10:50 0:15 Characterization of CHEK2-associated breast tumors

Svetlana Aleksakhina FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

10:50 11:00 0:10 Discussion11:00 11:10 0:10 Break11:10 12:05 Session 211:10 11:25 0:15 Determination of the possibility of intraoperative

detection of colorectal cancer histotypes by optical coherent elastography

Anton Plekhanov FSBEI HE«Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Nizhny Novgorod

11:25 11:40 0:15 Identification of WNT signaling genes associated with breast tumor metastasis

Nikolai Litvyakov Tomsk National Research Medical Center of the Russian Academy of Science

Tomsk

11:40 11:55 0:15 ALK, ROS1, RET translocations in lung cancer Vladislav Tyurin FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

11:55 12:05 0:10 Discussion12:05 13:15 1:10 Break13:15 14:15 Session 313:15 13:30 0:15 Analysis of multidrug resistance development in

soft tissue sarcoma cellsTimur Fetisov FSBI «N.N. Blokhin NMRC of oncology»

of the Ministry of Healthcare of the Russian Federation

Moscow

13:30 13:45 0:15 Coexpression of mRNA SNAI1 and RND3 and mRNA proteins of cytoskeleton in larynx and laryngopharynx squamous cell carcinoma

Gelena Kakurina Tomsk National Research Medical Center of the Russian Academy of Science

Tomsk

13:45 14:00 0:15 Fibroblast activation by human colorectal cancer cells: molecular and functional features

Irina Druzhkova FSBEI HE«Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Nizhny Novgorod

14:00 14:10 0:10 Discussion14:10 14:15 0:05 Break14:15 15:15 Session 414:15 14:30 0:15 Identification of proteins in exosomes associated

with the blood corpuscles surface in patients with breast cancer involved in tumor dissemination

Oleg Tutanov Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences

Novosibirsk

14:30 14:45 0:15 Analysis of microRNA expression profile in bone marrow cells in lymphoid and myeloid tumors

Yulia Veryaskina Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences

Novosibirsk

14:45 15:00 0:15 Whole transcriptome analysis of gene expression in a breast tumor with amplification of the chromosome 8 long arm

Marina Ibragimova Tomsk National Research Medical Center of the Russian Academy of Science

Tomsk


10:00 16:20 Palliative care for cancer patients10:00 13:45 Session 1. Symposium “Palliative medical care for cancer patients”


St. Petersburg


St. Petersburg

Chairs Diana Nevzorova I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow

Elena Polevichenko FSBEI Pirogov Russian National Research Medical University

Moscow

10:00 10:30 0:30 Palliative medical care for cancer patients: criteria, organization, necessity

Diana Nevzorova I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow

10:30 11:00 0:30 Organization of palliative care for children with cancer

Elena Polevichenko FSBEI Pirogov Russian National Research Medical University

Moscow

11:00 11:30 0:30 New WHO guidelines for management of cancer pain and Russian reality

Gyuzel Abuzarova P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia

Moscow

28.06.2020

Start(Moscow

time)

End(Moscow

time)


Institution City

11:30 12:00 0:30 Suicidal tendencies of cancer patients at the palliative stage


St. Petersburg

12:00 12:30 0:30 Patient navigation through the Cancer Care Continuum: outpatient, inpatient and hospice services

Svetlana Minchenko ST. Petesburg SAHI «Hospice (children)» St. Petersburg

12:30 13:00 0:30 Management of a terminal disease Olga Osetrova Noncommercial autonomous organization Samara`s Hospice

Samara

13:00 13:30 0:30 Hospice during a pandemic: psychological aspects. Following the example of St. Petersburg State Budgetary Healthcare Institution “Hospitage No. 1”

Margarita Vagaytseva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

13:30 13:45 0:15 Discussion13:45 14:00 0:15 Break14:00 16:20 Session 2. New opportunities in pain management as part of palliative care for cancer patients

Moderator Margarita Vagaytseva FSBI «N.N. Petrov NMRC of oncology» of the Ministry of Healthcare of the Russian Federation

St. Petersburg

Chairs Diana Nevzorova I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow


Moscow

14:00 14:30 0:30 Ensuring opioid analgetics availability for medical use. Principles of the application formation and sampling analysis of opioid analgetics and psychoactive substances

Lyudmila Shershakova Moscow Endocrine Plant Moscow

14:30 15:00 0:30 Russian opioid analgesics in the chronic pain treatment in adults. Safety and efficacy balance


Moscow

15:00 15:30 0:30 Effective dose selection principles and pain breakthroughs treatment

Diana Nevzorova I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow

15:30 16:00 0:30 Principles for predicting drug interactions and risk management in chronic pain treatment

Aleksander Sidorov FSBEI НЕ «Yaroslavl State Medical University» of the Ministry of Healthcare of the Russian Federation

Yaroslavl

16:00 16:20 0:20 Discussion

Documents

JUNE 25-28, 2020 WHITE NIGHTS